MCID: ASB003
MIFTS: 26

Asbestos Intoxication

Categories: Rare diseases, Respiratory diseases

Aliases & Classifications for Asbestos Intoxication

MalaCards integrated aliases for Asbestos Intoxication:

Name: Asbestos Intoxication 58
Asbestosis 58 71

Classifications:

Orphanet: 58  
Rare respiratory diseases


External Ids:

ICD10 via Orphanet 33 J61
UMLS via Orphanet 72 C0003949
Orphanet 58 ORPHA2302
UMLS 71 C0003949

Summaries for Asbestos Intoxication

MalaCards based summary : Asbestos Intoxication, also known as asbestosis, is related to asbestosis and anthracosis. The drugs Artichoke and Nintedanib have been mentioned in the context of this disorder. Affiliated tissues include lung, testes and neutrophil.

Related Diseases for Asbestos Intoxication

Diseases related to Asbestos Intoxication via text searches within MalaCards or GeneCards Suite gene sharing:

(showing 120, show less)
# Related Disease Score Top Affiliating Genes
1 asbestosis 12.8
2 anthracosis 11.7
3 interstitial lung disease 11.6
4 benign mesothelioma 10.9
5 silicosis 10.8
6 pneumoconiosis 10.7
7 pulmonary fibrosis 10.7
8 lung cancer 10.6
9 lung disease 10.6
10 mesothelioma, malignant 10.5
11 fibrosis of extraocular muscles, congenital, 1 10.5
12 pleural disease 10.5
13 pulmonary fibrosis, idiopathic 10.4
14 peritoneal mesothelioma 10.4
15 bronchitis 10.4
16 sarcoidosis 1 10.3
17 pulmonary tuberculosis 10.3
18 malignant pleural mesothelioma 10.3
19 pleurisy 10.2
20 adenocarcinoma 10.2
21 labrador lung 10.2
22 respiratory failure 10.2
23 diffuse pulmonary fibrosis 10.2
24 peripheral nervous system disease 10.2
25 neuropathy 10.2
26 mycobacterium tuberculosis 1 10.1
27 gastric cancer 10.1
28 aspergillosis 10.1
29 berylliosis 10.1
30 larynx cancer 10.1
31 glomerulonephritis 10.1
32 bronchiolitis 10.1
33 pneumonia 10.1
34 autoimmune disease 10.0
35 myeloma, multiple 10.0
36 lung cancer susceptibility 3 10.0
37 small cell carcinoma 10.0
38 pericarditis 10.0
39 systemic scleroderma 10.0
40 pleural cancer 10.0
41 extrinsic allergic alveolitis 10.0
42 bronchiectasis 10.0
43 47,xyy 10.0
44 back pain 10.0
45 colorectal cancer 9.9
46 systemic lupus erythematosus 9.9
47 neutrophil migration 9.9
48 ovarian cancer 9.9
49 pulmonary hypertension, primary, 1 9.9
50 small cell cancer of the lung 9.9
51 temporal arteritis 9.9
52 lymphoma, hodgkin, classic 9.9
53 multinucleated neurons, anhydramnios, renal dysplasia, cerebellar hypoplasia, and hydranencephaly 9.9
54 osteogenic sarcoma 9.9
55 interstitial pneumonitis, desquamative, familial 9.9
56 insulin-like growth factor i 9.9
57 anemia, x-linked, with or without neutropenia and/or platelet abnormalities 9.9
58 lymphoma, non-hodgkin, familial 9.9
59 pulmonary disease, chronic obstructive 9.9
60 lung cancer susceptibility 1 9.9
61 alpha/beta t-cell lymphopenia with gamma/delta t-cell expansion, severe cytomegalovirus infection, and autoimmunity 9.9
62 pulmonary alveolar proteinosis, acquired 9.9
63 sarcoidosis 3 9.9
64 cyanosis, transient neonatal 9.9
65 chorea, childhood-onset, with psychomotor retardation 9.9
66 deficiency anemia 9.9
67 pulmonary hypertension 9.9
68 lymphoma 9.9
69 angioimmunoblastic t-cell lymphoma 9.9
70 caplan's syndrome 9.9
71 siderosis 9.9
72 bacterial infectious disease 9.9
73 microinvasive gastric cancer 9.9
74 portal hypertension 9.9
75 sarcoma 9.9
76 constrictive pericarditis 9.9
77 cryptococcosis 9.9
78 pulmonary alveolar proteinosis 9.9
79 leukemia 9.9
80 pancytopenia 9.9
81 choreatic disease 9.9
82 allergic bronchopulmonary aspergillosis 9.9
83 pulmonary sarcoidosis 9.9
84 rete testis adenocarcinoma 9.9
85 pneumothorax 9.9
86 squamous cell carcinoma 9.9
87 mitral valve stenosis 9.9
88 vascular disease 9.9
89 papilloma 9.9
90 kidney cancer 9.9
91 lung sarcoma 9.9
92 idiopathic interstitial pneumonia 9.9
93 bronchiolitis obliterans 9.9
94 nonspecific interstitial pneumonia 9.9
95 signet ring cell adenocarcinoma 9.9
96 gallbladder adenocarcinoma 9.9
97 lung benign neoplasm 9.9
98 spindle cell sarcoma 9.9
99 carcinosarcoma 9.9
100 malignant biphasic mesothelioma 9.9
101 intestinal benign neoplasm 9.9
102 hemolytic anemia 9.9
103 adenoma 9.9
104 lung occult adenocarcinoma 9.9
105 rheumatoid arthritis interstitial lung disease 9.9
106 subacute delirium 9.9
107 vasculitis 9.9
108 bacterial pneumonia 9.9
109 lupus erythematosus 9.9
110 tracheitis 9.9
111 hypereosinophilic syndrome 9.9
112 banti's syndrome 9.9
113 microscopic polyangiitis 9.9
114 mycobacterium abscessus 9.9
115 polymyositis 9.9
116 retroperitoneal fibrosis 9.9
117 malignant peritoneal mesothelioma 9.9
118 systemic autoimmune disease 9.9
119 virus-associated trichodysplasia spinulosa 9.9
120 secondary pulmonary alveolar proteinosis 9.9

Graphical network of the top 20 diseases related to Asbestos Intoxication:



Diseases related to Asbestos Intoxication

Symptoms & Phenotypes for Asbestos Intoxication

Drugs & Therapeutics for Asbestos Intoxication

Drugs for Asbestos Intoxication (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(showing 4, show less)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1 Artichoke Approved Phase 2
2
Nintedanib Approved Phase 2 656247-17-5 56843413
3 Xenon Experimental Early Phase 1 7440-63-3
4 Respiratory System Agents

Interventional clinical trials:

(showing 12, show less)
# Name Status NCT ID Phase Drugs
1 Comparison of the Ultra-low-dose Veo Algorithm With the Gold Standard Filtered Back Projection for Detecting Pulmonary Asbestos-related Conditions Completed NCT01955018 Phase 4
2 Utility of Lung Clearance Index Score as a Noninvasive Marker of Small Airways Disease Recruiting NCT03241420 Phase 3
3 Investigation of the Anti-Cancer Activity of Artichoke Extract in an Asbestos-Exposed Population (The ABOCA Phase II Trial) Recruiting NCT02076672 Phase 2 Artichoke WPC
4 The Nintedanib in Progressive Pneumoconiosis Study (NiPPS): a Collaborative NSW Treatment Trial Not yet recruiting NCT04161014 Phase 2 Nintedanib 150 MG [Ofev]
5 OSCILLATION MECHANICS OF THE RESPIRATORY SYSTEM ASBESTOS EXPOSED : Early Diagnosis Unknown status NCT02280343
6 Idiopathic Pulmonary Fibrosis Job Exposures Study Completed NCT03211507
7 Linkage Study in Familial Pulmonary Fibrosis Completed NCT00016627
8 Specialized Center of Research in Occupational and Immunologic Lung Disease Completed NCT00005280
9 Molecular Epidemiology of Acute Respiratory Distress Syndrome Recruiting NCT00006496
10 The Edinburgh Lung Fibrosis Molecular Endotyping (ELFMEN) Study Enrolling by invitation NCT04016181
11 Developing Optimal Parameters for Hyperpolarized Noble Gas (3He and 129Xe) and Inert Fluorinated Gas Magnetic Resonance Imaging of Lung Disorders Not yet recruiting NCT02748798 Early Phase 1 HP 3He;HP 129Xe;PFP;SF6
12 It's Not JUST Idiopathic Pulmonary Fibrosis Study Suspended NCT03670576

Search NIH Clinical Center for Asbestos Intoxication

Genetic Tests for Asbestos Intoxication

Anatomical Context for Asbestos Intoxication

MalaCards organs/tissues related to Asbestos Intoxication:

40
Lung, Testes, Neutrophil, Lymph Node, Heart, T Cells, Nk Cells

Publications for Asbestos Intoxication

Articles related to Asbestos Intoxication:

(showing 2266, show less)
# Title Authors PMID Year
1
Asbestos-related diseases. 61
32553000 2020
2
Trends in Pneumoconiosis Deaths - United States, 1999-2018. 61
32525855 2020
3
Trends in global, regional and national incidence of pneumoconiosis caused by different aetiologies: an analysis from the Global Burden of Disease Study 2017. 61
32188634 2020
4
Increasing incidence of asbestosis worldwide, 1990-2017: results from the Global Burden of Disease study 2017. 61
32467338 2020
5
[Sustainability in Outpatient Pulmonary Rehabilitation in Patients with Asbestosis - Results of an 8-Year Follow Up]. 61
32053838 2020
6
Factors Affecting Asbestosis Mortality Among Asbestos-Cement Workers in Italy. 61
32328661 2020
7
Prognosis and causes of death of patients with acute exacerbation of fibrosing interstitial lung diseases. 61
32265195 2020
8
A Case of Autoimmune Pulmonary Alveolar Proteinosis with Pulmonary Fibrosis and Asbestosis-Like Features. 61
32336733 2020
9
The MUC5B promoter risk allele for idiopathic pulmonary fibrosis predisposes to asbestosis. 61
31949121 2020
10
The Wittenoom legacy. 61
31670764 2020
11
Familial Interstitial Lung Disease. 61
32279293 2020
12
Talc and mesothelioma: mineral fiber analysis of 65 cases with clinicopathological correlation. 61
32183579 2020
13
[Diagnostic Challenges of Mixed Dust Silicosis (Mixed Dust Pneumoconiosis) - 5 Case Reports]. 61
32052391 2020
14
Malignant Diffuse Mesothelioma in Women: A Study of 354 Cases. 61
31876584 2020
15
Mortality and mesothelioma incidence among chrysotile asbestos miners in Balangero, Italy: A cohort study. 61
31821579 2020
16
[Diffuse Intraparenchymal Mesothelioma: An Atypical Presentation]. 61
32035500 2020
17
Pleural Plaques and the Risk of Lung Cancer in Asbestos-exposed Subjects. 61
31433952 2020
18
NLRP3 and CARD8 polymorphisms influence risk for asbestos-related diseases. 61
32549782 2020
19
Follow-Up of the Libby, Montana Screening Cohort: A 17-Year Mortality Study. 61
31714372 2020
20
A case of hypersensitivity pneumonitis in a worker exposed to terephthalic acid in the production of polyethylene terephthalate. 61
31691678 2020
21
Occurrence, behaviour, and human exposure pathways and health risks of toxic geogenic contaminants in serpentinitic ultramafic geological environments (SUGEs): A medical geology perspective. 61
31693951 2020
22
[About the asbestos and the Position Paper on asbestos of the Italian Society of Occupational Medicine]. 61
32374117 2020
23
Analytical transmission electron microscopy of amosite asbestos from South Africa. 61
30702033 2020
24
Global use of asbestos - legitimate and illegitimate issues. 61
32549902 2020
25
Asbestos, Smoking and Lung Cancer: An Update. 61
31905913 2019
26
[Incidence and yrend of occupational pneumoconiosis in Ankang city from 1974 to 2017]. 61
31937033 2019
27
[The occurrence of asbestos-related diseases among former employees of asbestos processing plants in Poland]. 61
31682242 2019
28
Position Paper on Asbestos of the Italian Society of Occupational Medicine. 61
31846450 2019
29
[Idiopathic pleuroparenehymal fibroelastosis: report of one case and review of literature]. 61
31694096 2019
30
Pneumatosis intestinalis and pneumoretroperitoneum post steroid use in a patient with superior mesenteric artery syndrome. 61
31262624 2019
31
Asbestosis and silicosis hospitalizations in Italy (2001-2015): results from the National Hospital Discharge Registry. 61
30753424 2019
32
Relationship between pleural plaques and biomarkers of cumulative asbestos dose. A necropsy study. 61
31659992 2019
33
Bronchoalveolar cell differential count and the number of asbestos bodies correlate with survival in patients with asbestosis. 61
31331950 2019
34
Mortality of older construction and craft workers employed at department of energy nuclear sites: Follow-up through 2016. 61
31380577 2019
35
In vivo probe-based confocal laser endomicroscopy in chronic interstitial lung diseases: Specific descriptors and correlation with chest CT. 61
30811085 2019
36
NOX4 modulates macrophage phenotype and mitochondrial biogenesis in asbestosis. 61
31434799 2019
37
On the diagnosis of malignant pleural mesothelioma: A necropsy-based study of 171 cases (1997-2016). 61
29714657 2019
38
Cumulative asbestos exposure and mortality from asbestos related diseases in a pooled analysis of 21 asbestos cement cohorts in Italy. 61
31391078 2019
39
The natural course of lung function decline in asbestos exposed subjects with pleural plaques and asbestosis. 61
31226624 2019
40
Synthetic secoisolariciresinol diglucoside (LGM2605) inhibits Libby amphibole fiber-induced acute inflammation in mice. 61
31022494 2019
41
[Asbestos and its effects on health of Icelanders - review]. 61
31411568 2019
42
Mesothelioma mortality within two radiation monitored occupational cohorts. 61
31290725 2019
43
High frequency and severity of pleural changes in former workers exposed to anthophyllite associated with other contaminating amphibole asbestos in Brazil. 61
31046142 2019
44
Oxidative effects of lungs in Wistar rats caused by long-term exposure to four kinds of China representative chrysotile. 61
31055741 2019
45
Monitoring of airborne asbestos fibers in an urban ambient air of Shahryar City, Iran: levels, spatial distribution, seasonal variations, and health risk assessment. 61
30623323 2019
46
Imaging in idiopathic pulmonary fibrosis: diagnosis and mimics. 61
30726312 2019
47
Epithelial to Mesenchymal Transition in Human Mesothelial Cells Exposed to Asbestos Fibers: Role of TGF-β as Mediator of Malignant Mesothelioma Development or Metastasis via EMT Event. 61
30609805 2019
48
Interstitial Lung Diseases in Developing Countries. 61
30741505 2019
49
The Its Not JUST Idiopathic pulmonary fibrosis Study (INJUSTIS): description of the protocol for a multicentre prospective observational cohort study identifying biomarkers of progressive fibrotic lung disease. 61
31258922 2019
50
Transbronchial lung cryobiopsy: a novel confirmatory tool to diagnose asbestos-related pulmonary fibrosis. 61
30455954 2019
51
Outcomes after lung transplantation for patients with occupational lung diseases. 61
30506808 2019
52
Protocol for identification of airborne asbestos fibres in the urban areas and spatio-temporal trend. 61
31667124 2019
53
Analyzing biological and molecular characteristics and genomic damage induced by exposure to asbestos. 61
31239765 2019
54
An outbreak of cancer and asbestosis among former amosite-exposed subjects in Ledro Valley, Italy. From discovery to environmental cleanup. 61
30968842 2019
55
Shorter telomere length and DNA hypermethylation in peripheral blood cells of coal workers. 61
30442342 2018
56
[The German Mesothelioma Register : Current pathological diagnostics and services]. 61
30446780 2018
57
Dosimetry of inhaled elongate mineral particles in the respiratory tract: The impact of shape factor. 61
29738812 2018
58
Impact of asbestos on public health: a retrospective study on a series of subjects with occupational and non-occupational exposure to asbestos during the activity of Fibronit plant (Broni, Italy). 61
30687679 2018
59
Mortality among workers exposed to asbestos at the shipyard of Genoa, Italy: a 55 years follow-up. 61
30594195 2018
60
Measuring EMPs in the lung what can be measured in the lung: Asbestiform minerals and cleavage fragments. 61
29959999 2018
61
Monsanto, PCBs, and the creation of a "world-wide ecological problem". 61
30401808 2018
62
Spatial analysis of asbestos exposure and occupational health care in Poland during the period 2004-2013. 61
30451463 2018
63
WHO/ILO work-related burden of disease and injury: Protocol for systematic reviews of occupational exposure to dusts and/or fibres and of the effect of occupational exposure to dusts and/or fibres on pneumoconiosis. 61
29958118 2018
64
Breath analysis as a diagnostic and screening tool for malignant pleural mesothelioma: a systematic review. 61
30450290 2018
65
Occupational Burden of Asbestos-Related Diseases in Korea, 1998-2013: Asbestosis, Mesothelioma, Lung Cancer, Laryngeal Cancer, and Ovarian Cancer. 61
30140191 2018
66
Chrysotile and rock wool fibers induce chromosome aberrations and DNA damage in V79 lung fibroblast cells. 61
28685333 2018
67
Grade 4 asbestosis does not extend directly from the respiratory bronchiole to the peripheral lung. 61
29464753 2018
68
Evaluation of airborne asbestos exposure from routine handling of asbestos-containing wire gauze pads in the research laboratory. 61
29723551 2018
69
[Asbestosis and pleural plaques]. 61
29938630 2018
70
Asbestos exposure biomarkers in the follow-up of asbestos-exposed workers. 61
29479016 2018
71
Temporal Patterns of Exposure to Asbestos and Risk of Asbestosis: An Analysis of a Cohort of Asbestos Textile Workers. 61
29334525 2018
72
Global Asbestos Disaster. 61
29772681 2018
73
[Work-up of asbestosis and estimation of asbestos exposure in an occupational context]. 61
29808815 2018
74
Asbestos-related disease in upholsterers. 61
28686522 2018
75
Association between increased small airway obstruction and asbestos exposure in patients with asbestosis. 61
29087047 2018
76
Asbestosis is prevalent in a variety of construction industry trades. 61
29615629 2018
77
Biological responses to asbestos inhalation and pathogenesis of asbestos-related benign and malignant disease. 61
29306869 2018
78
[Health impact of asbestos fibres naturally occurring in Mount Pollino area (Basilicata Region, Southern Italy)]. 61
29774711 2018
79
[Diffuse Malignant Peritoneal Mesothelioma with Secondary Liver Invasion Diagnosed Using Laparoscopy - A Case Report]. 61
29650903 2018
80
Asbestos Exposures, Mesothelioma Incidence and Mortality, and Awareness by General Practitioners in the Molise Region, Central Italy. 61
29111984 2018
81
Characterization of pulmonary responses in mice to asbestos/asbestiform fibers using gene expression profiles. 61
29279043 2018
82
Histological findings and lung dust analysis as the basis for occupational disease compensation in asbestos-related lung cancer in Germany. 61
29099505 2018
83
Italian pool of asbestos workers cohorts: mortality trends of asbestos-related neoplasms after long time since first exposure. 61
28775133 2017
84
Chest physician-reported, work-related, long-latency respiratory disease in Great Britain. 61
29284684 2017
85
Polyvinylidene Fluoride Alters Inflammatory Responses by Activation-induced Cell Death in Macrophages. 61
29302253 2017
86
Differences between peritoneal and pleural mesothelioma in Lombardy, Italy. 61
29073511 2017
87
Serum concentrations of Krebs von den Lungen-6, surfactant protein D, and matrix metalloproteinase-2 as diagnostic biomarkers in patients with asbestosis and silicosis: a case-control study. 61
29149883 2017
88
[Pyopneumothorax in rheumatoid arthritis]. 61
29033202 2017
89
Parenchymal asbestosis due to primary asbestos exposure among ship-breaking workers: report of the first cases from Bangladesh. 61
29102973 2017
90
Metal load assessment in patient pulmonary lavages: towards a comprehensive mineralogical analysis including the nano-sized fraction. 61
29172825 2017
91
Mortality in asbestos cement workers in Pavia, Italy: A cohort study. 61
28833303 2017
92
Memory of World War II with loud atypical friction rub due to pulmonary asbestosis. 61
29054957 2017
93
Usual interstitial pneumonia: typical, possible, and "inconsistent" patterns. 61
29160385 2017
94
State-of-the-art nanopathological diagnostics. 61
28805487 2017
95
Correlation of ultra-low dose chest CT findings with physiologic measures of asbestosis. 61
28083692 2017
96
Survival in Good Performance Malignant Pleural Mesothelioma Patients; Prognostic Factors and Predictors of Response 61
28843224 2017
97
The evidence of benefits of exercise training in interstitial lung disease: a randomised controlled trial. 61
28213592 2017
98
Macrophages utilize the mitochondrial calcium uniporter for profibrotic polarization. 61
28351840 2017
99
Asbestos-related diseases in mineworkers: a clinicopathological study. 61
28852644 2017
100
SIRT3 deficiency promotes lung fibrosis by augmenting alveolar epithelial cell mitochondrial DNA damage and apoptosis. 61
28258190 2017
101
[Exploratory analysis on burden of disease attributable to asbestosis from 2006 to 2015]. 61
28780818 2017
102
Chest ultrasonography in health surveillance of asbestos-related lung diseases. 61
28162043 2017
103
Cancer Incidence in Asbestos-Exposed Workers: An Update on Four Finnish Cohorts. 61
28593073 2017
104
Pleural mesothelioma in household members of asbestos-exposed workers in Friuli Venezia Giulia, Italy. 61
28481375 2017
105
Calretinin as a blood-based biomarker for mesothelioma. 61
28558669 2017
106
New insights on 'old' toxicants in occupational toxicology (Review). 61
28339055 2017
107
Asbestos, asbestosis, and cancer: The Helsinki criteria for diagnosis and attribution. Critical need for revision of the 2014 update. 61
28409857 2017
108
Pemetrexed-related interstitial lung disease reported from post marketing surveillance (malignant pleural mesothelioma/non-small cell lung cancer). 61
28158568 2017
109
Long-term epidemiological observation of asbestos-related diseases in Poland, 1970-2015. 61
28204714 2017
110
[Analysis of changes in radiographic lung image and lung ventilation disorders in workers occupationally exposed to chrysotile in the past]. 61
28345684 2017
111
Mortality from asbestos-associated disease in Libby, Montana 1979-2011. 61
27025411 2017
112
Environmental asbestos disease: pleural plaque volume measurement with Chest Tomography is there a correlation between pulmonary function? 61
32476866 2017
113
Inflammasome as a Key Pathogenic Mechanism in Endometriosis. 61
27397068 2017
114
Serum HMGB1 as a Potential Biomarker for Patients with Asbestos-Related Diseases. 61
28348451 2017
115
High-resolution CT of the lungs: Indications and diagnosis. 61
29243467 2017
116
MicroRNA Expression in Malignant Pleural Mesothelioma and Asbestosis: A Pilot Study. 61
28757678 2017
117
Glycoprotein YKL-40 Levels in Plasma Are Associated with Fibrotic Changes on HRCT in Asbestos-Exposed Subjects. 61
28588347 2017
118
Plasma Fibulin-3 as a Potential Biomarker for Patients with Asbestos-Related Diseases in the Han Population. 61
29200597 2017
119
Migrating pleural plaque in a patient with asbestos induced pleural disease: a case report. 61
28855951 2017
120
Asbestos bodies in bronchoalveolar lavage in the 21st century: a time-trend analysis in a clinical population. 61
27550908 2017
121
Anthophyllite asbestos: state of the science review. 61
27397058 2017
122
[Characteristics of lung function in patients with asbestosis of different stages]. 61
27866549 2016
123
Pathology of Asbestosis: An Update of the Diagnostic Criteria Response to a Critique. 61
27575267 2016
124
Radiologic Diagnosis of Asbestosis in Korea. 61
27587956 2016
125
The NLRP3 inflammasome in pathogenic particle and fibre-associated lung inflammation and diseases. 61
27650313 2016
126
Usual interstitial pneumonia in asbestos-exposed cohorts - concurrent idiopathic pulmonary fibrosis or atypical asbestosis? 61
26864248 2016
127
Pleural irregularities and mediastinal pleural involvement in early stages of malignant pleural mesothelioma and benign asbestos pleural effusion. 61
27501894 2016
128
Medical monitoring of asbestos-exposed workers: experience from Poland. 61
27516637 2016
129
[Not Available]. 61
27464904 2016
130
Asbestos Fiber Preparation Methods Affect Fiber Toxicity. 61
27540559 2016
131
Multidetector CT Findings and Differential Diagnoses of Malignant Pleural Mesothelioma and Metastatic Pleural Diseases in Korea. 61
27390546 2016
132
Lung cancer risk in past asbestos workers a few decades after exposure cessation and prospects for screening. 61
26730642 2016
133
Idiopathic Pulmonary Fibrosis: Epidemiology, Clinical Features, Prognosis, and Management. 61
27231859 2016
134
Learning to identify the benign thoracic manifestations of asbestosis from a single patient. 61
27302641 2016
135
Effects of Chrysotile Exposure in Human Bronchial Epithelial Cells: Insights into the Pathogenic Mechanisms of Asbestos-Related Diseases. 61
26685284 2016
136
Fatal pleural mesothelioma in Japan (2003-2008): evaluation of computed tomography findings. 61
27015837 2016
137
Carcinoma of the lung in the absence of asbestosis: The value of lung fiber burden analysis. 61
27043967 2016
138
Exposure-response estimate for lung cancer and asbestosis in a predominantly chrysotile-exposed Chinese factory cohort. 61
26969815 2016
139
Asbestosis and other pulmonary fibrosis in asbestos-exposed workers: high-resolution CT features with pathological correlations. 61
26334510 2016
140
Diffuse malignant mesothelioma and synchronous lung cancer: A clinicopathological study of 18 cases. 61
27040844 2016
141
Asbestos-induced lung disease in small-scale clutch manufacturing workers. 61
28194083 2016
142
Asbestos exposure and laryngeal cancer mortality. 61
26418833 2016
143
Risk of occupational exposure to asbestos, silicon and arsenic on pulmonary disorders: Understanding the genetic-epigenetic interplay and future prospects. 61
26966890 2016
144
Crystal Formation in Inflammation. 61
26772211 2016
145
Asbestos content of lung tissue in patients with malignant peritoneal mesothelioma: A study of 42 cases. 61
27281118 2016
146
The comparison of high-resolution computed tomography findings in asbestosis and idiopathic pulmonary fibrosis. 61
26901505 2016
147
Lower limit of normal based spirometric abnormalities associated with radiographic abnormality in an elderly cohort at low risk for exposure. 61
27142581 2016
148
UK asbestos imports and mortality due to idiopathic pulmonary fibrosis. 61
26511746 2016
149
[The incidence of asbestos-related diseases about on asbestos enterprises in Qingdao from 1988 to 2014]. 61
27220441 2016
150
Asbestos exposure increases the incidence of histologically confirmed usual interstitial pneumonia. 61
26046696 2016
151
[Malignant pleural mesothelioma: rare and aggressive but with new therapeutic perspectives]. 61
30512336 2016
152
Multipolar mitosis and aneuploidy after chrysotile treatment: a consequence of abscission failure and cytokinesis regression. 61
26788989 2016
153
[Idiopatic pulmonary fibrosis - news in multidisciplinary diagnostic and therapeutic approaches]. 61
27223586 2016
154
ENOX2-based early detection (ONCOblot) of asbestos-induced malignant mesothelioma 4-10 years in advance of clinical symptoms. 61
26807072 2016
155
Distinction between mesothelioma and lung adenocarcinoma based on immunohistochemistry in a patient with asbestos bodies in bronchoalveolar fluid - case report. 61
28002541 2016
156
ACR Appropriateness Criteria Review ACR Appropriateness Criteria® Occupational Lung Diseases. 61
26656194 2016
157
[Financial compensation for asbestosis patients]. 61
27781966 2016
158
Focal pleural thickening mimicking pleural plaques on chest computed tomography: tips and tricks. 61
26539633 2016
159
Diagnostic Performance of Ultra-Low-Dose Computed Tomography for Detecting Asbestos-Related Pleuropulmonary Diseases: Prospective Study in a Screening Setting. 61
28033378 2016
160
Predicting the mortality from asbestos-related diseases based on the amount of asbestos used and the effects of slate buildings in Korea. 61
26513124 2016
161
[Proposal of an Italian national protocol of health surveillance for former asbestos workers: an ongoing project]. 61
26951736 2016
162
Tyler asbestos workers: A mortality update in a cohort exposed to amosite. 61
27705550 2016
163
Comments on the 2014 Helsinki Consensus Report on Asbestos. 61
27325081 2016
164
[Time trend in mesothelioma and lung cancer risk in asbestos workers in Italy]. 61
26951735 2016
165
Collegium Ramazzini response to 'Asbestos, asbestosis, and cancer, the Helsinki criteria for diagnosis and attribution 2014: recommendations'. 61
26637163 2016
166
Occupational lung disease survey of respiratory physicians in Northern Ireland. 61
26276755 2015
167
Exercise training to improve exercise capacity and quality of life in people with non-malignant dust-related respiratory diseases. 61
26544672 2015
168
Physical activity in people with asbestos related pleural disease and dust-related interstitial lung disease: An observational study. 61
26048393 2015
169
Asbestosis in a Japanese Macaque (Macaca fuscata). 61
26056144 2015
170
Commentary on pathologic diagnosis of asbestosis and critique of the 2010 Asbestosis Committee of the College of American Pathologists (CAP) and Pulmonary Pathology Society's (PPS) update on the diagnostic criteria for pathologic asbestosis. 61
26374489 2015
171
The Role of Mitochondrial DNA in Mediating Alveolar Epithelial Cell Apoptosis and Pulmonary Fibrosis. 61
26370974 2015
172
Accidental discovery of asbestos-related occupational pleural disease in unemployed carpenter: a healthcare safety net that needs mending. 61
26444343 2015
173
CT Characteristics of Pleural Plaques Related to Occupational or Environmental Asbestos Exposure from South Korean Asbestos Mines. 61
26357506 2015
174
Mesothelin (MSLN) methylation and soluble mesothelin-related protein levels in a Chinese asbestos-exposed population. 61
26188910 2015
175
Occupationally acquired asbestosis in a healthcare worker. 61
26253085 2015
176
The So-called Short-Fiber Controversy: Literature Review and Critical Analysis. 61
26230599 2015
177
A systematic review of the association between pleural plaques and changes in lung function. 61
25504898 2015
178
Alternative activation of macrophages and pulmonary fibrosis are modulated by scavenger receptor, macrophage receptor with collagenous structure. 61
25953850 2015
179
Chemokine (C-C motif) ligand 3 detection in the serum of persons exposed to asbestos: A patient-based study. 61
25940505 2015
180
Asbestos-related lung disease: a pictorial review. 61
25444537 2015
181
Asbestos-related lung cancer and malignant mesothelioma of the pleura: selected current issues. 61
26024342 2015
182
Systemic autoimmune disease in asbestosis rapidly responding to anti-interleukin-1beta antibody canakinumab: a case report. 61
26071911 2015
183
Gene-environment interaction from international cohorts: impact on development and evolution of occupational and environmental lung and airway disease. 61
26024343 2015
184
[Analysis of the clinical diagnosis of asbestosis complicated with malignant mesothelioma]. 61
26653237 2015
185
The c-Jun N-terminal kinase signaling pathway mediates chrysotile asbestos-induced alveolar epithelial cell apoptosis. 61
25530474 2015
186
Asbestosis: The Scam That Refuses to Die. 61
26168581 2015
187
Selenium and exposure to fibrogenic mineral dust: a mini-review. 61
25615721 2015
188
Mortality among sheet metal workers participating in a respiratory screening program. 61
25712482 2015
189
The mental health of asbestos-exposed subjects with pleural abnormalities. 61
25056610 2015
190
Parenchymal asbestosis can lead to lung cancer within a short time frame: more frequent follow-up surveillance is needed than currently recommended. 61
25878233 2015
191
[Case fatality rate in patients with pneumoconiosis in China: a meta-analysis]. 61
25916458 2015
192
Asbestosis and environmental causes of usual interstitial pneumonia. 61
25621562 2015
193
Retroperitoneal fibrosis and asbestosis--a plausible association? 61
25445100 2015
194
Pathological confirmed diagnosis of asbestosis: the first case report in Thailand. 61
25920303 2015
195
Indications for distinct pathogenic mechanisms of asbestos and silica through gene expression profiling of the response of lung epithelial cells. 61
25351596 2015
196
Idiopathic pulmonary fibrosis with emphysema: evidence of synergy among emphysema and idiopathic pulmonary fibrosis in smokers. 61
25389350 2015
197
Mortality of older construction and craft workers employed at department of energy (DOE) nuclear sites: follow-up through 2011. 61
25603938 2015
198
[Asbestos: An up-to-date general review]. 61
27476317 2015
199
[Review and perspective of a long-term follow-up of two cohorts of workers heavily exposed to asbestos]. 61
27476313 2015
200
Pleural plaques in smoking-associated fibrosis and pulmonary asbestosis. 61
25999705 2015
201
Smoking-associated fibrosis and pulmonary asbestosis. 61
25565798 2015
202
Asbestos-induced pulmonary fibrosis is augmented in 8-oxoguanine DNA glycosylase knockout mice. 61
24918270 2015
203
Risk assessment of gastric cancer associated with asbestosis: a case report. 61
25908993 2015
204
Asbestos, asbestosis, and cancer, the Helsinki criteria for diagnosis and attribution 2014: recommendations. 61
25299403 2015
205
Iron and Iron-Related Proteins in Asbestosis. 61
26756421 2015
206
Clinical Investigation of Benign Asbestos Pleural Effusion. 61
26689234 2015
207
Non-cancer diseases requiring admission to hospital among German seafarers. 61
25792159 2015
208
Screening of miners and millers at decreasing levels of asbestos exposure: comparison of chest radiography and thin-section computed tomography. 61
25790222 2015
209
Comparative long-term toxicity of Libby amphibole and amosite asbestos in rats after single or multiple intratracheal exposures. 61
25506632 2015
210
Review of carcinogenicity of asbestos and proposal of approval standards of an occupational cancer caused by asbestos in Korea. 61
26719804 2015
211
Asbestos related diseases among workers of asbestos processing plants in relation to type of production and asbestos use. 61
26016040 2015
212
Inter-reader agreement in HRCT detection of pleural plaques and asbestosis in participants with previous occupational exposure to asbestos. 61
25286915 2014
213
Lung Function Profiles among Individuals with Nonmalignant Asbestos-related Disorders. 61
25516818 2014
214
[Need for occupational and environmental allergology in occupational health - the 45th Japanese society of Occupational and Environmental Allergy Annual Meeting 2014 in Fukuoka]. 61
25501761 2014
215
Asbestos-induced disruption of calcium homeostasis induces endoplasmic reticulum stress in macrophages. 61
25324550 2014
216
Extracellular signal-regulated kinase 5 and cyclic AMP response element binding protein are novel pathways inhibited by vandetanib (ZD6474) and doxorubicin in mesotheliomas. 61
24940987 2014
217
Exercise training for asbestos-related and other dust-related respiratory diseases: a randomised controlled trial. 61
25407957 2014
218
Asbestos: use, bans and disease burden in Europe. 61
25378740 2014
219
The clinicopathological characteristics with long-term outcomes in malignant mesothelioma. 61
25208819 2014
220
Clinical aspects of asbestos-related diseases--what are the unresolved topics? 61
25285978 2014
221
Differential diagnosis of usual interstitial pneumonia: when is it truly idiopathic? 61
25176967 2014
222
AKT/mTOR and c-Jun N-terminal kinase signaling pathways are required for chrysotile asbestos-induced autophagy. 61
24735948 2014
223
Pulmonary tuberculosis complicating asbestosis. 61
24914084 2014
224
Malignant pleural mesothelioma: a single-center experience in Turkey. 61
24842043 2014
225
Asbestos modulates thioredoxin-thioredoxin interacting protein interaction to regulate inflammasome activation. 61
24885895 2014
226
Dust diseases and the legacy of corporate manipulation of science and law. 61
24999846 2014
227
Spiroergometric parameters at maximal exercise testing assessed functional respiratory impairment in asbestos-induced fibrosis. 61
24028216 2014
228
Molecular mechanisms of crystal-related kidney inflammation and injury. Implications for cholesterol embolism, crystalline nephropathies and kidney stone disease. 61
24163269 2014
229
[Asbestos-related diseases]. 61
24605531 2014
230
The role of the inflammasome in fibrotic respiratory diseases. 61
24572449 2014
231
Diseases attributable to asbestos exposure: years of potential life lost, United States, 1999-2010. 61
24108494 2014
232
Asbestosis, not asbestos exposure, is the primary risk factor for lung cancer. 61
24381996 2014
233
Asbestos, asbestosis, smoking, and lung cancer: study bias and confounding issues that complicate the interpretation of the results. 61
24381997 2014
234
[A case of surgical treatment for a bilateral pneumothorax that occurred in a patient with severe asbestosis and advanced emphysema]. 61
24800531 2014
235
Radiological surveillance of formerly asbestos-exposed power industry workers: rates and risk factors of benign changes on chest X-ray and MDCT. 61
24808921 2014
236
[Main results of research concerning asbestos-related diseases in Kazakhstan Republic]. 61
25549453 2014
237
Asbestos and the lung in the 21st century: an update. 61
23711077 2014
238
[Industrial injury insurance system in the UK]. 61
24334699 2013
239
YKL-40 and mesothelin in the blood of patients with malignant mesothelioma, lung cancer and asbestosis. 61
24324091 2013
240
The diagnosis and treatment of idiopathic pulmonary fibrosis. 61
24529303 2013
241
Asbestos-induced alveolar epithelial cell apoptosis. The role of endoplasmic reticulum stress response. 61
23885834 2013
242
[Malignant pleural mesothelioma: 2013 state of the art]. 61
24225007 2013
243
Pulmonary toxicity of carbon nanotubes and asbestos - similarities and differences. 61
23899865 2013
244
Diffusing capacity and forced vital capacity in 5,003 asbestos-exposed workers: relationships to interstitial fibrosis (ILO profusion score) and pleural thickening. 61
24038345 2013
245
The role of asbestos morphology on their cellular toxicity: an in vitro 3D Raman/Rayleigh imaging study. 61
23846589 2013
246
[Asbestos exposure in the petrochemical industry and interaction with other occupational risk factors: analysis of the last ten years INAIL data]. 61
24303712 2013
247
The latency period of mesothelioma among a cohort of British asbestos workers (1978-2005). 61
23989951 2013
248
Asbestos-Induced Gastrointestinal Cancer: An Update. 61
27158561 2013
249
MetLife and its corporate allies: dust diseases and the manipulation of science. 61
24588035 2013
250
Descriptive review of asbestosis and silicosis hospitalization trends in North Carolina, 2002-2011. 61
24165760 2013
251
Post-occupational health surveillance of asbestos workers. 61
24180083 2013
252
Short, fine and WHO asbestos fibers in the lungs of quebec workers with an asbestos-related disease. 61
23532794 2013
253
Potential years of life lost (PYLL) caused by asbestos-related diseases in the world. 61
23907860 2013
254
Asbestos, asbestosis, smoking, and lung cancer. New findings from the North American insulator cohort. 61
23590275 2013
255
Mortality among shipbreaking workers in Taiwan--a retrospective cohort study from 1985 to 2008. 61
23532723 2013
256
[A patient with asbestosis, chorea and neuropsychiatric symptoms]. 61
23695943 2013
257
Bronchoalveolar neutrophilia inversely correlates with DLCO at diagnosis in asbestosis but not lung function decline at 1 year. 61
23825766 2013
258
Occupational diseases in Poland--an overview of current trends. 61
24018997 2013
259
[Analyses on the characteristics and the trends of pneumoconiosis notified between 1997 and 2009, in China]. 61
23803520 2013
260
Divergence of tight and adherens junction factors in alveolar epithelium in pulmonary fibrosis. 61
23253490 2013
261
Altered functions of alveolar macrophages and NK cells involved in asbestos-related diseases. 61
23463177 2013
262
Comparison of chest digital tomosynthesis and chest radiography for detection of asbestos-related pleuropulmonary disease. 61
23177084 2013
263
Environmental scanning electron microscopy technique to identify asbestos phases inside ferruginous bodies. 61
23442447 2013
264
[Asbestos and harmful health effects: from denial theories to epidemiological evidence]. 61
23743702 2013
265
Mimics in chest disease: interstitial opacities. 61
23247773 2013
266
Differential distribution of lymphatic clearance between upper and lower regions of the lung. 61
23121047 2013
267
Cause-specific mortality in a Chinese chrysotile textile worker cohort. 61
23121131 2013
268
[Asbestos pulmonary content in workers of Ferrol shipyards, Spain]. 61
22440140 2013
269
Molecular basis of asbestos-induced lung disease. 61
23347351 2013
270
Malignant mesothelioma of the pericardium: a report of two different presentations. 61
24027648 2013
271
The influence of gene-gene and gene-environment interactions on the risk of asbestosis. 61
23984360 2013
272
Calcium oxalate crystals induce renal inflammation by NLRP3-mediated IL-1β secretion. 61
23221343 2013
273
[Pulmonary disease due to asbestos in steel industry workers]. 61
23732197 2013
274
Longitudinal decline in lung function in former asbestos exposed workers. 61
23014595 2013
275
Is an individual prediction of maximal work rate by 6-minute walk distance and further measurements reliable in male patients with different lung diseases? 61
23363649 2013
276
Silicon: the health benefits of a metalloid. 61
24470100 2013
277
[Inflammasome--essential regulator of the inflammatory reaction]. 61
23720939 2013
278
The worldwide pandemic of asbestos-related diseases. 61
23297667 2013
279
Pulmonary tuberculosis and lung cancer mortality in a historical cohort of workers with asbestosis. 61
23164612 2012
280
[Incidence of asbestosis and other benign lung diseases: Spain, 1962-2010]. 61
23325136 2012
281
[Comparative study of direct digital radiography and film-screen radiography in diagnosis of asbestosis]. 61
23257031 2012
282
[Asbestosis still exists…]. 61
23200587 2012
283
Lung and pleural fibrosis in asbestos-exposed workers: a risk factor for pneumonia mortality. 61
22214835 2012
284
Mortality from asbestosis and mesothelioma in Britain by birth cohort. 61
23034792 2012
285
Elimination of asbestos use and asbestos-related diseases: an unfinished story. 61
22726320 2012
286
Adipokine adipsin is associated with the degree of lung fibrosis in asbestos-exposed workers. 61
22832039 2012
287
[The different pleuro-pulmonary pathologies related to asbestos: definitions, epidemiology and evolution]. 61
23101644 2012
288
Asbestosis: Past voices from the Mumbai factory floor. 61
23776323 2012
289
Asbestos-related diseases in Thailand and review literature. 61
23130478 2012
290
Interleukin gene polymorphisms in pneumoconiosis. 61
22580886 2012
291
[Do advers health effects of chrysotile and amphibole asbestos differ?]. 61
22875734 2012
292
The validity of static lung compliance in asbestos-induced diseases. 61
22526865 2012
293
Peroxiredoxins and tropomyosins as plasma biomarkers for lung cancer and asbestos exposure. 61
22537621 2012
294
[Idiopathic eosinophilic pleural effusion--case report]. 61
23133914 2012
295
An updated review on asbestos and related diseases in China. 61
23026008 2012
296
SP-1 regulation of MMP-9 expression requires Ser586 in the PEST domain. 61
22519702 2012
297
Asbestos exposure induces alveolar epithelial cell plasticity through MAPK/Erk signaling. 61
22573546 2012
298
[Dose and effect biomarkers in the diagnosis of asbestos-related diseases and health surveillance of exposed workers]. 61
23405721 2012
299
[Asbestos: fifty years of work exposure in Campania and other Italian regions through INAIL experience]. 61
23405712 2012
300
Cryptococcus pneumonia presenting in an immunocompetent host with pulmonary asbestosis: a case report. 61
22742509 2012
301
[Screening of differentially expressed serum proteins in patients with asbestosis]. 61
22931765 2012
302
[Pitfalls in diagnostic imaging and assessment of benign asbestos-related thoracic diseases]. 61
22549551 2012
303
Mesothelioma and lung cancer mortality: a historical cohort study among asbestosis workers in Hong Kong. 61
22129857 2012
304
Safety and effectiveness of pemetrexed in patients with malignant pleural mesothelioma based on all-case drug-registry study. 61
21890228 2012
305
Exposure-response relationship between chrysotile exposure and mortality from lung cancer and asbestosis. 61
21742741 2012
306
Analysis of mortality in chrysotile asbestos miners in China. 61
22282260 2012
307
Incidence of the pneumoconioses in the United Kingdom general population between 1997 and 2008. 61
22678015 2012
308
Leukotrienes B4, C4, D4 and E4 in the exhaled breath condensate (EBC), blood and urine in patients with pneumoconiosis. 61
22785421 2012
309
Long-term response of rats to single intratracheal exposure of Libby amphibole or amosite. 61
22251266 2012
310
Asbestos-induced cellular and molecular alteration of immunocompetent cells and their relationship with chronic inflammation and carcinogenesis. 61
22500091 2012
311
A cohort study of mortality predictors and characteristics of patients with combined pulmonary fibrosis and emphysema. 61
22587885 2012
312
Asbestos-related diseases in automobile mechanics. 61
21965465 2012
313
Evaluation of sensitivity of fluorescence-based asbestos detection by correlative microscopy. 61
21932006 2012
314
[A comprehensive review of literature to investigate development of global knowledge and consensus on asbestos carcinogenicity: up to the report and recommendations by UICC Working Group in 1964]. 61
22449815 2012
315
Squamotous-type sarcomatoid carcinoma of the lung with rhabdomyosarcomatous components. 61
22531538 2012
316
A baseline profile of asbestos in the US-affiliated Pacific Islands. 61
22550694 2012
317
Mitochondrial Rac1 GTPase import and electron transfer from cytochrome c are required for pulmonary fibrosis. 61
22157762 2012
318
Long-term efficacy of pulmonary rehabilitation in patients with occupational respiratory diseases. 61
22652634 2012
319
[Follow-up of subjects occupationally exposed to asbestos, what are the objectives, the benefits, and the possible risks?]. 61
22152932 2011
320
Government and Navy knowledge regarding health hazards of asbestos: a state of the science evaluation (1900 to 1970). 61
22200078 2011
321
Asbestosis in Louisiana: a descriptive review and demographic analysis of hospitalizations for abestosis, 1999-2009. 61
22324095 2011
322
[Analysis of asbestos bodies and nude fibres in the lung parenchyma of operated lung cancers. A retrospective monocentric study of 73 cases]. 61
22017949 2011
323
Mortality trends in asbestosis, extrinsic allergic alveolitis and sarcoidosis in England and Wales. 61
21704503 2011
324
Preventive measures to eliminate asbestos-related diseases in singapore. 61
22953203 2011
325
Occupational exposure to asbestos and ovarian cancer: a meta-analysis. 61
21642044 2011
326
Differences among peritoneal and pleural mesothelioma: data from the Lombardy Region Mesothelioma Register (Italy). 61
22022760 2011
327
A retrospective study of chest pain in benign asbestos pleural disease. 61
21834915 2011
328
[Case report of a rare occupational disease: a during life non-recognised occupational disease--talcosis]. 61
21412706 2011
329
Malignant peritoneal mesothelioma presenting as recurrent adhesion obstruction in general surgery: a case report. 61
21878098 2011
330
Cardiac calcification in acute intermittent porphyria. 61
21976884 2011
331
Biomarkers in malignant mesothelioma: diagnostic and prognostic role of soluble mesothelin-related peptide. 61
21928246 2011
332
The risk of asbestos exposure in South African diamond mine workers. 61
21742625 2011
333
[Asbestos-related diseases observed in Palermo (Italy) among workers exposed to asbestos]. 61
22033203 2011
334
[Analysis of occupational diseases in Lazio region: a comparison between Italian and foreign workers]. 61
23393824 2011
335
Talc asbestosis and pulmonary tuberculosis in a patient exposed to the talc used in the production of soccer balls. 61
21881748 2011
336
Asbestos-related cancer risk in patients with asbestosis or pleural plaques. 61
21742228 2011
337
Regarding "absence of radiographic asbestosis and the risk of lung cancer among asbestos-cement workers: extended follow-up of a cohort", by Murray Finkelstein, American Journal of Industrial Medicine 2010. 61
21328422 2011
338
[What are the tools for post-occupational follow-up, how should they be performed and what are their performance, limits and benefit/risk ratio? Chest X-Ray and CT scan]. 61
21742237 2011
339
[A case of pulmonary Mycobacterium abscessus infection with asbestosis in a patient given multidisciplinary treatment]. 61
21688648 2011
340
Asbestos-related disease. 61
21309996 2011
341
Comparison of functional, biochemical, and morphometric alterations in the lungs of 4 rat strains and hamsters following repeated intratracheal instillation of crocidolite asbestos. 61
21309734 2011
342
Osteopontin modulates inflammation, mucin production, and gene expression signatures after inhalation of asbestos in a murine model of fibrosis. 61
21514415 2011
343
Chest pain in asbestos and silica-exposed workers. 61
21406408 2011
344
An elderly man with fibrotic lung disease. Asbestosis, pleural plaques, and rounded atelectasis. 61
21484007 2011
345
Asbestos-related disease in Bangladeshi ship breakers: a pilot study. 61
21618946 2011
346
Mitochondrial Cu,Zn-superoxide dismutase mediates pulmonary fibrosis by augmenting H2O2 generation. 61
21393238 2011
347
Proteomic detection of cancer in asbestosis patients using SELDI-TOF discovered serum protein biomarkers. 61
21231887 2011
348
Acute exacerbations of fibrotic interstitial lung disease. 61
20854464 2011
349
Clinical, radiological, and pathological investigation of asbestosis. 61
21556185 2011
350
Lung diffusing capacity relates better to short-term progression on HRCT abnormalities than spirometry in mild asbestosis. 61
21298694 2011
351
The role of iron in tumour cell proliferation. 61
21324793 2011
352
Asbestosis. 61
21281828 2011
353
Inducible nitric oxide synthase genetic polymorphism and risk of asbestosis. 61
21660141 2011
354
Occupational epidemiology in the real world: Irving Selikoff, odds ratios, and asbestosis. 61
24484362 2011
355
Real world occupational epidemiology, part 1: odds ratios, relative risk, and asbestosis. 61
24484370 2011
356
Occult adenocarcinoma of the lung mimicking rapid progression of asbestosis. 61
21532232 2011
357
Mortality study in an asbestos cement factory in Naples, Italy. 61
21952156 2011
358
Work-related lung diseases. 61
22997873 2011
359
[Implementation of the Amiantus project involving prophylactic medical examinations of the former employees of asbestos processing plants]. 61
22312960 2011
360
Mysterious link between iron overload and CDKN2A/2B. 61
21297911 2011
361
Enhanced expression of Fas Ligand (FasL) in the lower airways of patients with fibrotic interstitial lung diseases (ILDs). 61
22252758 2011
362
Pulmonary endpoints (lung carcinomas and asbestosis) following inhalation exposure to asbestos. 61
21534086 2011
363
[Clinical and epidemiologic aspects of tuberculosis in asbestosis patients in connection with dust load]. 61
21789803 2011
364
A camel through the eye of a needle: expertise and the late recognition of asbestos-related diseases. 61
21319725 2011
365
Oxidative stress markers in exhaled breath condensate in lung fibroses are not significantly affected by systemic diseases. 61
22020018 2011
366
[Opinions and expectations of patients with health problems associated to asbestos exposure]. 61
21532644 2011
367
Pulmonary inflammatory and fibrotic responses in Fischer 344 rats after intratracheal instillation exposure to Libby amphibole. 61
21797767 2011
368
Mesothelioma and asbestosis in a young woman following occupational asbestos exposure: Short latency and long survival: Case Report. 61
21162719 2010
369
Molecular mechanisms of asbestos-induced lung epithelial cell apoptosis. 61
20380827 2010
370
Asbestosis and mesothelioma among British asbestos workers (1971-2005). 61
20957726 2010
371
Absence of radiographic asbestosis and the risk of lung cancer among asbestos-cement workers: Extended follow-up of a cohort. 61
20672325 2010
372
Dysregulation of the immune system caused by silica and asbestos. 61
20849352 2010
373
CT scan screening is associated with increased distress among subjects of the APExS. 61
20977751 2010
374
[Immunological effects of silica/asbestos]. 61
20885075 2010
375
Breath analysis in asbestos-related disorders: a review of the literature and potential future applications. 61
21383477 2010
376
Does asbestos exposure cause airway obstruction, in the absence of confirmed asbestosis? 61
20442438 2010
377
Does asbestos exposure (asbestosis) cause (clinical) airway obstruction (small airway disease)? 61
20713640 2010
378
Tumour necrosis factor-alpha gene polymorphisms in asbestos-induced diseases. 61
20486865 2010
379
Occupational toxicology of asbestos-related malignancies. 61
20849338 2010
380
[Asbestos-related diseases of the thorax]. 61
20521020 2010
381
Pulmonary inflammation in asbestos-exposed subjects with borderline parenchymal changes on HRCT. 61
20163943 2010
382
Analytical characterization of cell-asbestos fiber interactions in lung pathogenesis. 61
20490468 2010
383
Decreased Cyp2E1 mRNA expression in human leucocytes in patients with fibrotic and inflammatory lung diseases. 61
20514434 2010
384
Patterns of pulmonary dysfunction in asbestos workers: a cross-sectional study. 61
20525229 2010
385
Clinical study of asbestos-related lung cancer in Japan with special reference to occupational history. 61
20331622 2010
386
Vermiculite worker mortality: estimated effects of occupational exposure to Libby amphibole. 61
20431408 2010
387
Crocidolite induces prostaglandin I(2) release mediated by vitronectin receptor and cyclooxygenase-2 in lung cells. 61
20155273 2010
388
Prospective study of asbestos-related diseases incidence cases in primary health care in an area of Barcelona province. 61
20412567 2010
389
Clinical significance of serum vascular endothelial growth factor in malignant pleural mesothelioma. 61
20357617 2010
390
Clinically occult interstitial fibrosis in smokers: classification and significance of a surprisingly common finding in lobectomy specimens. 61
20004953 2010
391
Mesothelioma risk associated with asbestos production in Slovenia. 61
20338867 2010
392
Sarcomatoid mesothelioma: a clinical-pathologic correlation of 326 cases. 61
20081811 2010
393
Pathology of asbestosis- An update of the diagnostic criteria: Report of the asbestosis committee of the college of american pathologists and pulmonary pathology society. 61
20196674 2010
394
[Short- and long-term effects of the outpatient medical rehabilitation for patients with asbestosis]. 61
19918720 2010
395
Parenchymal and airway diseases caused by asbestos. 61
20104177 2010
396
Asbestos fiber content of lungs with diffuse interstitial fibrosis: An analytical scanning electron microscopic analysis of 249 cases. 61
20196673 2010
397
LC-ESI-MS/MS method for oxidative stress multimarker screening in the exhaled breath condensate of asbestosis/silicosis patients. 61
21386209 2010
398
[Imaging of fibrosing interstitial pneumonias]. 61
21166124 2010
399
[Pneumoconiosis: high-resolution CT characteristics and patho-physiology]. 61
20337058 2010
400
[Improvement of lasting effects in outpatient pulmonary rehabilitation with special regard to exercise therapy and sports]. 61
20178059 2010
401
[Effect of asbestos fibre dust exposures on lung function--a systematic review]. 61
20143281 2010
402
Inhalational lung disease. 61
23022777 2010
403
Detection of lung cancer in silicosis patients using a tumor-marker panel. 61
20660960 2010
404
Analysis on the co-localization of asbestos bodies and Fas or CD163 expression in asbestos lung tissue by in-air micro-pixe. 61
20377990 2010
405
Risk assessment of lung cancer and asbestosis in workers exposed to asbestos fibers in brake shoe factory in Iran. 61
20160406 2010
406
Cancer mortality in a surveillance cohort of German males formerly exposed to asbestos. 61
19783208 2010
407
Clinical and HRCT screening of heavily asbestos-exposed workers. 61
19756698 2010
408
Longitudinal changes in pulmonary function of asbestos workers. 61
20679738 2010
409
Selective detection of airborne asbestos fibers using protein-based fluorescent probes. 61
20000675 2010
410
Environmental asbestos-related pleural plaque in southeast of Turkey. 61
20147001 2010
411
CYP1A1 and CYP1B1 polymorphisms as modifying factors in patients with pneumoconiosis and occupationally related tumours: A pilot study. 61
21475938 2009
412
[A model to diagnose occupational, asbestos-related pneumoconiosis and thickening of the pleura]. 61
20853781 2009
413
[Croatian and international regulations on the protection and rights of workers exposed to asbestos at work]. 61
20853780 2009
414
[Immunological aspects of asbestos-related diseases]. 61
20853778 2009
415
Population-based asbestosis surveillance in British Columbia. 61
19528044 2009
416
[Incidence and prevalence of asbestos-related diseases in Croatia]. 61
20853775 2009
417
Malignant peritoneal mesothelioma: quantitative analysis of asbestos burden. 61
19883435 2009
418
[Expectations after ban on asbestos]. 61
20853774 2009
419
Blockade of a chemokine, CCL2, reduces chronic colitis-associated carcinogenesis in mice. 61
19773434 2009
420
Asbestosis: demonstration of distinctive interstitial fibroelastosis: a pilot study. 61
19751905 2009
421
[Relevance of pathological examinations and lung dust analyses in the context of asbestos-associated lung cancer-No. 4104 of the list of occupational diseases in Germany]. 61
19768667 2009
422
Biopersistence and potential adverse health impacts of fibrous nanomaterials: what have we learned from asbestos? 61
20049814 2009
423
Rheumatoid pneumoconiosis (Caplan's syndrome) with a classical presentation. 61
19820822 2009
424
Mortality of older construction and craft workers employed at Department of Energy (DOE) nuclear sites. 61
19670258 2009
425
Lung cancer mortality and fibre exposures among North Carolina asbestos textile workers. 61
19282317 2009
426
Rapid and easy method for monitoring oxidative stress markers in body fluids of patients with asbestos or silica-induced lung diseases. 61
19574111 2009
427
Mortality among sheet metal workers participating in a medical screening program. 61
19562730 2009
428
Asbestos exposure and benign asbestos diseases in 772 formerly exposed workers: dose-response relationships. 61
19533676 2009
429
Exhaled breath condensate biomarkers in asbestos-related lung disorders. 61
19520561 2009
430
Asbestos-related disease among sheet metal workers 1986-2004: radiographic changes over time. 61
19479897 2009
431
Mortality among British asbestos workers undergoing regular medical examinations (1971-2005). 61
19254909 2009
432
Pleural plaques and asbestosis: dose- and time-response relationships based on HRCT data. 61
19129281 2009
433
Clinical presentation of asbestosis with intractable pleural pain in the adult child of a taconite miner and radiographic demonstration of the probable pathology causing the pain. 61
19650581 2009
434
Association of transforming growth factor beta1 gene polymorphisms and asbestos-induced fibrosis and tumors. 61
19349911 2009
435
Antemortem diagnosis of asbestosis by screening chest radiograph correlated with postmortem histologic features of asbestosis: a study of 273 cases. 61
19523203 2009
436
Interobserver variations in diagnosing asbestosis according to the ILO classification. 61
19581213 2009
437
Asbestosis mortality in the USA: facts and predictions. 61
19017689 2009
438
Functional inactivation of NF2/merlin in human mesothelioma. 61
18835652 2009
439
[Asbestos-related cancer risk in the presence of asbestosis or pleural plaques]. 61
19421094 2009
440
Asbestos-induced lung diseases: an update. 61
19304273 2009
441
Serum growth factors in asbestosis patients. 61
19283526 2009
442
Osteopontin levels in an asbestos-exposed population. 61
19174489 2009
443
Primary localized malignant biphasic mesothelioma of the liver in a patient with asbestosis. 61
19195066 2009
444
Chitotriosidase activity in sarcoidosis and some other pulmonary diseases. 61
19347743 2009
445
Manganese and extracellular superoxide dismutase polymorphisms and risk for asbestosis. 61
19636420 2009
446
Palliative care services for those with chronic lung disease. 61
19176708 2009
447
[Asbestos fibre lung burden and exposure indices in asbestos-cement workers]. 61
19263869 2009
448
[Non-medicamentous correction of changes in the cardiovascular and respiratory systems in subjects exposed to chrysolite asbestos dust]. 61
19284111 2009
449
Asbestosis and catalase genetic polymorphism. 61
19064360 2008
450
Asbestos-related occupational lung diseases in NSW, Australia and potential exposure of the general population. 61
19088405 2008
451
The burden of exposure-related diffuse lung disease. 61
19221957 2008
452
Asbestosis-related years of potential life lost before age 65 years--United States, 1968-2005. 61
19078920 2008
453
Proportionate mortality study of the United Association of Journeymen and Apprentices of the Plumbing and Pipe Fitting Industry. 61
18942099 2008
454
X ray pictures in 88% of Michigan doctor's asbestosis diagnoses were found to be normal. 61
19017716 2008
455
[Evaluation of serum fibrosis markers in asbestos-exposed workers]. 61
19068759 2008
456
Diagnostic and prognostic value of soluble mesothelin-related proteins in patients with malignant pleural mesothelioma in comparison with benign asbestosis and lung cancer. 61
18978568 2008
457
[Recycle of jute bags; asbestos in agriculture, exposure and pathology ]. 61
19344084 2008
458
[Diagnosis in related pathologic asbestosis, clinical case of a suspected occupational neoplasm]. 61
19344083 2008
459
Human health effects associated with the commercial use of grunerite asbestos (amosite): Paterson, NJ; Tyler, TX; Uxbridge, UK. 61
18022741 2008
460
Increased 8-isoprostane, a marker of oxidative stress in exhaled breath condensate in subjects with asbestos exposure. 61
18840939 2008
461
[Evaluation of rounded atelectasis induced by exposure to asbestos]. 61
18939412 2008
462
DNA-based sputum cell image analysis for lung cancer in a clinical setting. 61
18833822 2008
463
Soluble mesothelin-related protein in malignant pleural mesothelioma. 61
20424652 2008
464
An epidemiological study of the role of chrysotile asbestos fibre dimensions in determining respiratory disease risk in exposed workers. 61
18096653 2008
465
Novel functional view of the crocidolite asbestos-treated A549 human lung epithelial transcriptome reveals an intricate network of pathways with opposing functions. 61
18687144 2008
466
The Nalp3 inflammasome is essential for the development of silicosis. 61
18577586 2008
467
Asbestosis mortality surveillance in the United States, 1970-2004. 61
18686715 2008
468
Asbestos-induced MKP-3 expression augments TNF-alpha gene expression in human monocytes. 61
18314537 2008
469
In-air micro-particle induced X-ray emission analysis of asbestos and metals in lung tissue. 61
18831923 2008
470
Mesothelioma mortality in Brazil, 1980-2003. 61
18686716 2008
471
[Mortality in the cohort of the asbestos cement workers in the Eternit plant in Casale Monferrato (Italy)]. 61
19186504 2008
472
Genetic susceptibility to malignant pleural mesothelioma and other asbestos-associated diseases. 61
18420450 2008
473
Induced sputum markers of fibrosis and decline in pulmonary function in asbestosis and silicosis: a pilot study. 61
18544209 2008
474
Cancer mortality and asbestosis among workers in an asbestos plant in Chongqing, China. 61
18714817 2008
475
[Occupational exposure and occurrence of pneumoconioses in Campinas, Brazil, 1978-2003]. 61
18622503 2008
476
Modelling prevalence and incidence of fibrosis and pleural plaques in asbestos-exposed populations for screening and follow-up: a cross-sectional study. 61
18570653 2008
477
Select mortality and cancer incidence among residents in various U.S. communities that received asbestos-contaminated vermiculite ore from Libby, Montana. 61
18569099 2008
478
Determination of 8-iso-prostaglandin F(2alpha) in exhaled breath condensate using combination of immunoseparation and LC-ESI-MS/MS. 61
18373964 2008
479
Twenty-five years of fiber analysis: what have we learned? 61
18187182 2008
480
Immunological changes in mesothelioma patients and their experimental detection. 61
21157517 2008
481
Two cases of asbestosis and one case of rounded atelectasis due to non-occupational asbestos exposure. 61
18507198 2008
482
Immunological alterations found in mesothelioma patients and supporting experimental evidence. 61
19568881 2008
483
Relationship between induced sputum cytology and inflammatory status with lung structural and functional abnormalities in asbestosis. 61
18213643 2008
484
[Procedures in the case of suspicion of asbestosis]. 61
18351513 2008
485
Sensitive and specific new enzyme-linked immunosorbent assay for N-ERC/mesothelin increases its potential as a useful serum tumor marker for mesothelioma. 61
18316566 2008
486
[Macroscopic subtypes of asbestosis in relation to the amount of asbestos in 63 Japanese autopsy cases]. 61
18318247 2008
487
Iron homeostasis in the lung following asbestos exposure. 61
17999626 2008
488
[Virtual pleuroscopy of diaphragmatic pleura: myth or reality?]. 61
18603174 2008
489
Risk stratification of chest pain patients in the emergency department by a nurse utilizing a point of care protocol. 61
18180660 2008
490
Extracellular superoxide dismutase protects against matrix degradation of heparan sulfate in the lung. 61
17961072 2008
491
A case of pulmonary asbestosis presenting with temporal arteritis involving multiple medium-sized vessels. 61
18159568 2008
492
[Symptoms of asbestos-related diseases and correction of hemodynamic and ventilation changes in asbestosis patients]. 61
18467972 2008
493
The influence of genetic polymorphisms of GSTP1 on the development of asbestosis. 61
18188076 2008
494
[Cancer morbidity risks among workers of asbestos-cement productions]. 61
18467971 2008
495
[Clinical and functional characteristics of broncho-pulmonary system under exposure to chrysotile-asbestos dust]. 61
18389956 2008
496
[WHO and ILO Program on elimination of asbestos-related diseases]. 61
18461796 2008
497
[Asbestos as a risk factor for pulmonary diseases]. 61
19621651 2008
498
The defence of chrysotile, 1912-2007. 61
18320733 2008
499
[Benign asbestos-related pleuropulmonary diseases]. 61
18216750 2007
500
[Malignant pleural mesothelioma: interrogations and hopes concerning the expected epidemic]. 61
18166941 2007
501
Spirometry, rapid FEV1 decline, and lung cancer among asbestos exposed heavy smokers. 61
18027161 2007
502
Dynamics of the lung function in asbestos pleural disease. 61
18063525 2007
503
[Genetic damages in somatic and germ cells from patients of benzene poisoning, asbestosis and gas poisoning.]. 61
18226370 2007
504
[Pulmonary asbestosis: an autopsy case]. 61
18064879 2007
505
Cut-off-independent tumour marker evaluation using ROC approximation. 61
18214036 2007
506
Bronchoalveolar lavage in occupational lung diseases. 61
17975778 2007
507
Follow-up study of chrysotile textile workers: cohort mortality and exposure-response. 61
17449563 2007
508
[Asbestosis--physical examination and symptoms]. 61
18044480 2007
509
[Interferon gamma (IFN-gamma) level in broncholaveolar lavage (BAL) fluid is positively correlated with CD4/CD8 ratio in selected interstitial lung diseases]. 61
18051824 2007
510
A fuzzy-classifier using a marker panel for the detection of lung cancers in asbestosis patients. 61
17649786 2007
511
[Family mesotheliomas: genetic interaction with environmental carcinogenic exposure?]. 61
17723954 2007
512
[Medical surveillance of previously asbestos-exposed workers: report of a case of lung cancer with high level of serum mesothelin]. 61
18409717 2007
513
[Estimate of the previous exposure to asbestos through mineralogical examination of the bronchoalveolar lavage (BAL) fluid in a population working in a sugar industry]. 61
18411447 2007
514
[Asbestos-related diseases in relatives of asbestos exposed workers]. 61
18409714 2007
515
Increased alveolar nitric oxide concentration and high levels of leukotriene B(4) and 8-isoprostane in exhaled breath condensate in patients with asbestosis. 61
17251310 2007
516
[Health surveillance in workers with a previous exposure to asbestos: a method of retrospective evaluation of exposition]. 61
18409883 2007
517
[Asbestos: a long lasting tragedy. Useful considerations for a historical reconstruction of the most remarkable facts]. 61
18050861 2007
518
Decision guarantee in tumour marker analysis: a cut-off independent assessment. 61
17649799 2007
519
Glutathione S-transferases GSTM1 and GSTT1 polymorphisms and asbestosis. 61
17563610 2007
520
[Contribution of immunohistochemistry to the management of lung cancer: from morphology to diagnosis and treatment]. 61
17675942 2007
521
[Computed tomographic atlas of benign asbestos related pathology]. 61
17632435 2007
522
[Computed tomographic atlas of benign asbestos related pathology]. 61
17652978 2007
523
[Malignant mesothelioma of the pleura in a truck driver]. 61
17598349 2007
524
[Case of tuberculous pleurisy with eosinophilic pleural effusion and hematological eosinophilia]. 61
17564128 2007
525
Asbestos-related diseases of the lungs and pleura: uses, trends and management over the last century. 61
17394680 2007
526
Vermiculite, respiratory disease, and asbestos exposure in Libby, Montana: update of a cohort mortality study. 61
17450227 2007
527
Gene expression profiles in asbestos-exposed epithelial and mesothelial lung cell lines. 61
17331233 2007
528
[Mortality in a cohort of asbestos cement workers in Carrara, Italy]. 61
17375608 2007
529
[Management of malignant pleural effusion]. 61
17583136 2007
530
Asbestos-related lung disease. 61
17375514 2007
531
Lessons from the silicosis and asbestosis mass tort scams. 61
17536431 2007
532
Information from your family doctor. Asbestosis: what you should know. 61
17375515 2007
533
Ecological association between asbestos-related diseases and historical asbestos consumption: an international analysis. 61
17350453 2007
534
Inhalational talc pneumoconiosis: radiographic and CT findings in 14 patients. 61
17242238 2007
535
Radiographic readings for asbestosis: misuse of science--validation of the ILO classification. 61
17154406 2007
536
[Case of asbestosis with massive benign pleural involvement]. 61
17663051 2007
537
Mesothelin family proteins and diagnosis of mesothelioma: analytical evaluation of an automated immunoassay and preliminary clinical results. 61
17484626 2007
538
[Malignant pleural cancers mortality and compensated cases for asbestos related diseases in Lazio municipalities (1980-2001)]. 61
17240643 2007
539
Malignant pleural mesothelioma with scalp, cerebellar, and finger metastases: a rare case. 61
17269529 2007
540
Asbestos-induced and smoking-related disease: apportioning pulmonary function deficit by using thin-section CT. 61
17090711 2007
541
Genetic predisposition and health effect of occupational exposure to asbestos. 61
17159790 2006
542
COX-2 is widely expressed in metaplastic epithelium in pulmonary fibrous disorders. 61
17050069 2006
543
Retrospective mortality cohort study of Italian workers compensated for silicosis. 61
16847031 2006
544
[The relation of asbestosis to human 8-oxoguanine DNA glycosidase polymorphism and DNA damage in peripheral lymphocytes]. 61
17313735 2006
545
A review of the federal government's health activities in response to asbestos-contaminated ore found in Libby, Montana. 61
16920666 2006
546
Expression of the T cell receptor Vbeta repertoire in a human T cell resistant to asbestos-induced apoptosis and peripheral blood T cells from patients with silica and asbestos-related diseases. 61
17166401 2006
547
Involvement of IL-10 and Bcl-2 in resistance against an asbestos-induced apoptosis of T cells. 61
16850164 2006
548
Intracellular protein binding to asbestos induces aneuploidy in human lung fibroblasts. 61
16937396 2006
549
24 years of pneumoconiosis mortality surveillance in Australia. 61
17053296 2006
550
Measurements of asbestos burden in tissues. 61
17119209 2006
551
Asbestos consumption, asbestos exposure and asbestos-related occupational diseases in Germany. 61
16523318 2006
552
Matrix metalloproteinases promote inflammation and fibrosis in asbestos-induced lung injury in mice. 61
16574944 2006
553
Respiratory health in Turkish asbestos cement workers: the role of environmental exposure. 61
16691614 2006
554
[Asbestosis and microfiber role]. 61
17144416 2006
555
[Lung cancer in a female non-smoker with occupational exposure to asbestos: a case report]. 61
17017384 2006
556
Association between polymorphisms of DNA repair gene XRCC1 and DNA damage in asbestos-exposed workers. 61
16944782 2006
557
Diagnosis of asbestos-related pleuropolmonary diseases. 61
17009682 2006
558
Fractional exhaled nitric oxide concentration is increased in asbestosis and pleural plaques. 61
16635093 2006
559
Adverse effects of asbestos exposure and smoking on lung function. 61
16570255 2006
560
Increased sensitivity to asbestos-induced lung injury in mice lacking extracellular superoxide dismutase. 61
16458190 2006
561
Assessment of asbestos in drinking water in alexandria, egypt. 61
17382060 2006
562
Pneumoconiosis: comparison of imaging and pathologic findings. 61
16418244 2006
563
Expression of insulin-like growth factor-I (IGF-I) in alveolar macrophages and lymphocytes obtained by bronchoalveolar lavage (BAL) in interstitial lung diseases (ILD). Assessment of IGF-I as a potential local mitogen and antiapoptotic cytokine. 61
17219718 2006
564
Malignant mesothelioma in Hong Kong. 61
15941656 2006
565
The role of analytical SEM in the determination of causation in malignant mesothelioma. 61
16517468 2006
566
Silico-asbestosis that responded to steroid therapy. 61
16946575 2006
567
[Other pneumoconioses]. 61
17273600 2006
568
[Asbestos-related diseases]. 61
17273598 2006
569
[Imaging in occupational lung diseases]. 61
17273603 2006
570
[Prophylactic examinations of workers formerly employed in asbestos processing plants: outcome of the Amiantus project in 2000-2004]. 61
16871953 2006
571
The effect of asbestosis on lung cancer risk beyond the dose related effect of asbestos alone. 61
16299098 2005
572
Stability of ferruginous bodies in human lung tissue following death, embalmment, and burial. 61
16282156 2005
573
[Studies on insulin-like growth factor-I expression in human lower airways]. 61
16498797 2005
574
Nonmalignant pleural lesions due to environmental exposure to asbestos: a field-based, cross-sectional study. 61
16264049 2005
575
Evidence for excess colorectal cancer incidence among asbestos-exposed men in the Beta-Carotene and Retinol Efficacy Trial. 61
16177148 2005
576
Biomarkers in risk assessment of asbestos exposure. 61
16112146 2005
577
[Asbestos and malignant pleural mesothelioma: molecular, cellular and physiopathological aspects]. 61
16316830 2005
578
The additional risk of malignant mesothelioma in former workers and residents of Wittenoom with benign pleural disease or asbestosis. 61
16169910 2005
579
Asbestosis in an asbestos composite mill at Mumbai: a prevalence study. 61
16262892 2005
580
[Rounded atelectasis: a follow up of 10 years by CT]. 61
16358662 2005
581
Mining and mendacity, or how to keep a toxic product in the marketplace. 61
16350474 2005
582
[Asbestos-related pleuropulmonary diseases: pictorial essay]. 61
16288346 2005
583
[Pleural cancer mortality and compensated cases of asbestosis in Sardinia Region municipalities (1980-2000)]. 61
16646264 2005
584
Effects of asbestos and smoking on gas diffusion in people exposed to crocidolite. 61
16097914 2005
585
Poly(ADP-ribosyl)ation in asthma and other lung diseases. 61
15911336 2005
586
Asbestos problem in India. 61
15950810 2005
587
Asbestos lung residue and asbestosis risk. 61
15933073 2005
588
Plasma concentrations of retinol, carotene, and vitamin E and mortality in subjects with asbestosis in a cohort exposed to crocidolite in Wittenoom, Western Australia. 61
15951717 2005
589
[Intrahepatic cholangiocarcinoma: case report]. 61
16437896 2005
590
Asbestos, asbestosis, and lung cancer: a critical assessment of the epidemiological evidence. 61
15860721 2005
591
Occupational medicine in the Slovene area. 61
15953840 2005
592
Induction of CD69 antigen expression in peripheral blood mononuclear cells on exposure to silica, but not by asbestos/chrysotile-A. 61
15790520 2005
593
p53 autoantibodies predict subsequent development of cancer. 61
15523685 2005
594
Predictors of lung cancer among asbestos-exposed men in the {beta}-carotene and retinol efficacy trial. 61
15671258 2005
595
The art of perpetuating a public health hazard. 61
15706173 2005
596
[Occupational mortality in Italy during 1992, assessed through record-linkage between pension records and death certificates]. 61
15871618 2005
597
Asbestos in the non-mining industry on the Witwatersrand, South Africa. 61
15762249 2005
598
Asbestos lung residue and asbestosis risk. 61
15591074 2005
599
[Asbestosis]. 61
15915170 2005
600
A proportionate mortality study of bricklayers and allied craftworkers. 61
15597362 2005
601
Mortality from malignant neoplasms among workers of an asbestos processing plant in Poland: results of prolonged observation. 61
16617847 2005
602
[Mesothelioma: the aetiological role of ultrathin fibres and repercussions on prevention and medical legal evaluation]. 61
15847104 2005
603
[Wonder matter and assassin. The perception of the asbestos danger as a mirror of the time 1930-1990]. 61
15991441 2005
604
Lung function changes in pleural asbestosis. 61
15666603 2004
605
Proposed criteria for mixed-dust pneumoconiosis: definition, descriptions, and guidelines for pathologic diagnosis and clinical correlation. 61
15619211 2004
606
Regarding 'mortality, morbidity, and asbestosis in New Zealand: the hidden legacy of asbestos exposure'. 61
15608814 2004
607
After Helsinki: a multidisciplinary review of the relationship between asbestos exposure and lung cancer, with emphasis on studies published during 1997-2004. 61
15841689 2004
608
Effects of asbestos and smoking on the levels and rates of change of lung function in a crocidolite exposed cohort in Western Australia. 61
15563704 2004
609
Mortality, morbidity, and asbestosis in New Zealand: the hidden legacy of asbestos exposure. 61
15570336 2004
610
Normal pulmonary capillary blood volume in patients with chronic infiltrative lung disease and high pulmonary artery pressure. 61
15539713 2004
611
Assessment of 18F-fluorodeoxyglucose dual-head gamma camera in asbestos lung diseases. 61
15516678 2004
612
Redistribution of pulmonary EC-SOD after exposure to asbestos. 61
15298984 2004
613
The British approach to asbestos standard setting: 1898-2000. 61
15490473 2004
614
Prior lung disease and risk of lung cancer in a large prospective study. 61
15456995 2004
615
Mineral fiber problems and their management: UK 1890-1935. 61
15307129 2004
616
Asbestos and mesothelioma in South Africa. 61
15261425 2004
617
Changing patterns of pneumoconiosis mortality--United States, 1968-2000. 61
15269698 2004
618
Differences in mortality by radiation monitoring status in an expanded cohort of Portsmouth Naval Shipyard workers. 61
15247807 2004
619
Asbestosis and probable microscopic polyangiitis. 61
15332139 2004
620
[Mortality study of asbestos cement workers in Emilia-Romagna]. 61
15732678 2004
621
Emphysema findings associated with heavy asbestos-exposure in high resolution computed tomography of finnish construction workers. 61
15308825 2004
622
Chrysophiles versus chrysophobes: the white asbestos controversy, 1950s-2004. 61
15490967 2004
623
[A case of MPO-ANCA-related vasculitis after asbestos exposure with progression of a renal lesion after improvement of interstitial pneumonia]. 61
15228136 2004
624
Factors associated with early-stage pulmonary fibrosis as determined by high-resolution computed tomography among persons occupationally exposed to asbestos. 61
15250649 2004
625
[Standardized CT/HRCT-classification of the German Federal Republic for work and environmental related thoracic diseases]. 61
15094995 2004
626
Occupational health research in India. 61
15128163 2004
627
Dose-Response Relationships in Expression of Biomarkers of Cell Proliferation in in vitro Assays and Inhalation Experiments. 61
19330127 2004
628
Why did the barber acquire asbestosis? 61
15078787 2004
629
Asbestosis in the Republic of Croatia. 61
15281379 2004
630
The epidemic of asbestos-related diseases in New Zealand. 61
15281382 2004
631
Asbestos in the sputum, crackles in the lungs, and radiologic changes in women exposed to asbestos. 61
15281383 2004
632
Concentration of hydroxyproline in blood: a biological marker in occupational exposure to asbestos and its relationship with Pi*Z and Pi*S polymorphism in the alpha-1 antitrypsin gene. 61
14748049 2004
633
[Apoptosis of bronchoalveolar lavage lymphocytes (L-BAL) in pneumoconiosis]. 61
15521573 2004
634
[Diseases caused by asbestos dust and the trend of their development in exposed workers in 1951-2003]. 61
16106740 2004
635
The impact of teleconsultations at a referential centre on the management of pulmonary patients. 61
15718598 2004
636
Asbestos induces tissue factor in Beas-2B human lung bronchial epithelial cells in vitro. 61
15636197 2004
637
Environmental and occupational health hazards associated with the presence of asbestos in brake linings and pads (1900 to present): a "state-of-the-art" review. 61
14681081 2004
638
Effect of platelet-derived growth factor on the development and persistence of asbestos-induced fibroproliferative lung disease. 61
15511213 2004
639
Asbestosis and idiopathic pulmonary fibrosis: comparison of thin-section CT features. 61
14576443 2003
640
The application of new technologies in diagnosing occupational asbestosis. 61
14994646 2003
641
CT findings and serum ca 125 levels in malignant peritoneal mesothelioma: report of 11 new cases and review of the literature. 61
14634783 2003
642
[Talc pneumoconiosis among soapstone handicraft workers in a rural area of Ouro Preto, Minas Gerais, Brazil]. 61
14999341 2003
643
[Pneumoconiosis and mycobacterial infection]. 61
14672049 2003
644
Synchronous diffuse malignant mesothelioma and carcinomas in asbestos-exposed individuals. 61
14511258 2003
645
Malignant and non-malignant asbestos-related pleural and lung disease: 10-year follow-up study. 61
14515425 2003
646
Asbestos exposure and antineutrophil cytoplasmic Antibody (ANCA) positivity. 61
15562639 2003
647
Previously undetected silicosis in New Jersey decedents. 61
12929151 2003
648
The clinical diagnosis of asbestosis in this century requires more than a chest radiograph. 61
12970045 2003
649
Trends in asbestos body counts in bronchoalveolar lavage fluid over two decades. 61
14516145 2003
650
Pneumoconiosis in a vermiculite end-product user. 61
12874855 2003
651
A case of asbestosis? 61
12973874 2003
652
Bilateral environmental and occupational health program with India. 61
12971687 2003
653
Occupational characteristics of cases with asbestos-related diseases in The Netherlands. 61
12890657 2003
654
Haemorrhagic pericardial effusion in an asbestos worker. 61
14526498 2003
655
High-resolution CT of asbestosis and idiopathic pulmonary fibrosis. 61
12818850 2003
656
Impaired cardiac autonomic functions in patients with environmental asbestos exposure: a study of time domain heart rate variability. 61
12942481 2003
657
Scientific controversy and asbestos: making disease invisible. 61
12967155 2003
658
Asbestos in Belgium: use and abuse. 61
12967167 2003
659
A cross-country comparative overview of the asbestos situation in ten Asian countries. 61
12967160 2003
660
[Pulmonary asbestosis]. 61
12910896 2003
661
Commentary regarding the article by Fischer et al.: Fibre years, pulmonary asbestos burden and asbestosis. Int. J. Hyg. Environ. Health 205, 245-248 (2002). 61
12872536 2003
662
Commentary regarding the article by Fischer et al.: Fibre years, pulmonary asbestos burden and asbestosis. Int. J. Hyg. Environ. Health 205, 245-248 (2002). 61
12872537 2003
663
Asbestos-induced pulmonary toxicity: role of DNA damage and apoptosis. 61
12773695 2003
664
Multinucleated giant cells in bronchoalveolar lavage. 61
12789926 2003
665
Asbestos: old foe in 21st century developing countries. 61
12711421 2003
666
Multiple roles of oxidants in the pathogenesis of asbestos-induced diseases. 61
12706492 2003
667
Clinical study of asbestos-related lung cancer. 61
12725469 2003
668
Occupational lung disease. Part 2. Discovering the cause of diffuse parenchymal lung disease. 61
12718237 2003
669
Immunocytological and mineralogical study of bronchoalveolar lavage in a group of subjects exposed to asbestos. 61
12872499 2003
670
[Effect of age on asbestosis of the lung and/or pleura]. 61
14574769 2003
671
Radiographic (ILO) readings predict arterial oxygen desaturation during exercise in subjects with asbestosis. 61
12598668 2003
672
Three decades of pleural cancer and mesothelioma registration in Austria where asbestos cement was invented. 61
12733090 2003
673
Respiratory impairment due to asbestos exposure in brake-lining workers. 61
12648477 2003
674
Persistent localization of activated extracellular signal-regulated kinases (ERK1/2) is epithelial cell-specific in an inhalation model of asbestosis. 61
12598305 2003
675
Unusual intraparenchymal growth patterns of malignant pleural mesothelioma. 61
12558747 2003
676
Incidence of cancer among the participants of the Finnish Asbestos Screening Campaign. 61
12630438 2003
677
[Diffuse interstitial lung disorders caused by the environment and occupation]. 61
14964037 2003
678
Rare findings in high resolution computed tomography (HRCT) in interstitial lung diseases. 61
15323225 2003
679
[Clinical research in the field of occupational diseases (pneumonology aspects)]. 61
12768956 2003
680
Asbestos related diseases from environmental exposure to crocidolite in Da-yao, China. I. Review of exposure and epidemiological data. 61
12499455 2003
681
[Findings in a high-risk group following asbestos exposure. Benefit of ENT examinations in patients with long-term exposure to asbestos]. 61
12420184 2002
682
Pi*S and Pi*Z alpha 1 antitrypsin polymorphism and the risk for asbestosis in occupational exposure to asbestos. 61
12368052 2002
683
Positron emission tomography imaging in nonmalignant thoracic disorders. 61
12524653 2002
684
Asbestos: when the dust settles an imaging review of asbestos-related disease. 61
12376609 2002
685
Apportionment in asbestos-related disease for purposes of compensation. 61
12502232 2002
686
Respiratory conditions in Malaysian asbestos cement workers. 61
12440274 2002
687
[Compensated cases for asbestosis. A geographical analysis by Italian provinces]. 61
12524935 2002
688
Effect of occupational silica exposure on pulmonary function. 61
12171857 2002
689
Does asbestos exposure cause non-Hodgkin's lymphoma or related hematolymphoid cancers? A review of the epidemiologic literature. 61
12141953 2002
690
In vivo bioassays of acute asbestosis and its correlation with ESR spectroscopy and imaging in redox status. 61
12162455 2002
691
Asbestos-induced alveolar epithelial cell apoptosis: role of mitochondrial dysfunction caused by iron-derived free radicals. 61
12162428 2002
692
Fibre-years, pulmonary asbestos burden and asbestosis. 61
12040923 2002
693
[Application value of measurement of the regional pulmonary ventilation by electric impedance pneumograph in the clinical diagnosis of pneumoconiosis]. 61
14694624 2002
694
Manganese superoxide dismutase genotypes and asbestos-associated pulmonary disorders. 61
11849743 2002
695
Fatal asbestosis 50 years after brief high intensity exposure in a vermiculite expansion plant. 61
11956059 2002
696
Patterns of lung diseases in former mine workers of the former Republic of the Transkei: an X-ray-based study. 61
12019676 2002
697
Computed tomography of asbestos-related pleural abnormalities. 61
11981655 2002
698
Asbestos-related disease. 61
11933817 2002
699
[Mortality in a cohort of asbestos cement workers in Bari]. 61
12125387 2002
700
[Clinical evaluation of rounded atelectasis induced by exposure to asbestos]. 61
11974876 2002
701
High-resolution CT in the evaluation of occupational and environmental disease. 61
11813819 2002
702
Chronic immune activation and inflammation in the pathogenesis of AIDS and cancer. 61
11883529 2002
703
Mechanisms of colchicine effect in the treatment of asbestosis and idiopathic pulmonary fibrosis. 61
12172901 2002
704
[The incidence of asbestosis in Poland]. 61
12577804 2002
705
Mortality study of workers compensated for asbestosis in Poland, 1970-1997. 61
12462454 2002
706
[Asbestos-related carcinogenic risk]. 61
12701533 2002
707
[Prophylactic examinations of former workers of asbestos processing plants: the Amiantus project]. 61
12701534 2002
708
The attribution of lung cancers to asbestos exposure: a pathologic study of 924 unselected cases. 61
11789737 2002
709
Amiodarone pneumonitis diagnosed by gallium-67 scintigraphy. 61
16352069 2002
710
[Clinical utility and safety of diagnostic thoracoscopy]. 61
11875804 2001
711
Fate of the miraculous mineral--ban asbestos worldwide campaign. 61
11811303 2001
712
Can semi-automated image cytometry on induced sputum become a screening tool for lung cancer? Evaluation of quantitative semi-automated sputum cytometry on radon- and uranium-exposed workers. 61
11829100 2001
713
[Contribution to the anatomopathologic study of pulmonary asbestosis. 1949]. 61
11899928 2001
714
[Asbestosis and pulmonary carcinoma in a female asbestos fibre spinner (remarks on the cancer problem of asbestos). 1955]. 61
11899934 2001
715
Non-malignant asbestos-related diseases in Brazilian asbestos-cement workers. 61
11598970 2001
716
Dust-induced interstitial lung disease in the tropics. 61
11584175 2001
717
Occupational asthma in Singapore. 61
11764055 2001
718
Malignant mesothelioma from neighborhood exposure to anthophyllite asbestos. 61
11494349 2001
719
[Incidence of malignant mesothelioma (1980-1999) and asbestos exposure in 190 cases diagnosed among residents of the province of Brescia]. 61
11676187 2001
720
Transgenic mouse models to determine the role of epidermal growth factor receptor in epithelial cell proliferation, apoptosis, and asbestosis. 61
11451897 2001
721
Pulmonary function in long-term asbestos workers in China. 61
11464393 2001
722
Changes in low molecular weight DNA fragmentation in white blood cells of workers highly exposed to asbestos. 61
11516066 2001
723
Asbestos causes apoptosis in alveolar epithelial cells: role of iron-induced free radicals. 61
11329530 2001
724
The role of environmental and occupational exposures in Turkish immigrants with fibre-related disease. 61
11488327 2001
725
A patient with asbestos-induced lung cancer complicated by silicosis. 61
11341551 2001
726
Mortality among unionized construction plasterers and cement masons. 61
11323787 2001
727
Epidemiology of occupational asbestos-related diseases in China. 61
11341561 2001
728
High-resolution computed tomography classification of lung fibrosis for patients with asbestos-related disease. 61
11409592 2001
729
Diagnosis of pulmonary alveolar proteinosis: usefulness of papanicolaou-stained smears of bronchoalveolar lavage fluid. 61
11252115 2001
730
[Asbestosis and sarcoid-like thoracic lesions: a case report]. 61
11373601 2001
731
Malignant mesothelioma in Japan: analysis of registered autopsy cases. 61
11256861 2001
732
Radicular involvement and medullary invasion from a malignant mesothelioma. 61
11223742 2001
733
Free radical activity of natural and heat treated amphibole asbestos. 61
11237261 2001
734
Carcinogenicity of asbestos: convincing evidence, conflicting interests. 61
11242699 2001
735
Science or public relations? The inside story of the Asbestosis Research Council, 1957-1990. 61
11071693 2000
736
Autopsy cases of asbestosis in Japan: a statistical analysis on registered cases. 61
11128884 2000
737
National Occupational Health Service policies and programs for workers in small-scale industries in China. 61
11192218 2000
738
Respiratory symptoms and functional status in workers exposed to silica, asbestos, and coal mine dusts. 61
11094786 2000
739
Diagnosis and management of asbestosis. 61
11126482 2000
740
[Identification and mortality of Italian emigrants returning to Italy after having worked in the crocidolite mines at Wittenoon Gorge, Western Australia]. 61
11219202 2000
741
[Pleural and parenchymal lung diseases from asbestos exposure. CT diagnosis]. 61
11213409 2000
742
Sarcoid-like pulmonary lesions during asbestosis. A case report. 61
11033848 2000
743
[A case of pulmonary fibrosis with many asbestos bodies in bronchoalveolar lavage fluid after exposure to asbestos and man-made mineral fibers]. 61
11186929 2000
744
Asbestosis and lobar site of lung cancer. 61
10769303 2000
745
Asbestos exposure, lung cancer and asbestosis. 61
10949878 2000
746
Increased phosphorylated extracellular signal-regulated kinase immunoreactivity associated with proliferative and morphologic lung alterations after chrysotile asbestos inhalation in mice. 61
10751356 2000
747
In vitro cleavage by asbestos fibers of the fifth component of human complement through free-radical generation and kallikrein activation. 61
10777245 2000
748
Pathology and pathophysiology of pneumoconiosis. 61
10741774 2000
749
The prevalence of pleural plaques and/or pulmonary changes among construction workers in Okayama, Japan. 61
10642419 2000
750
The past and present of pneumoconioses. 61
10741776 2000
751
Prevalence and features of advanced asbestosis (ILO profusion scores above 2/2). International Labour Office. 61
10821510 2000
752
Asbestos content of lung tissue and carcinoma of the lung: a clinicopathologic correlation and mineral fiber analysis of 234 cases. 61
10717262 2000
753
Sister chromatid exchange rate from pleural fluid cells in patients with malignant mesothelioma. 61
10708982 2000
754
[Granulomatous lung lesions after occupational exposure to glass fibers]. 61
11004867 2000
755
[Genetic polymorphism and occupational diseases: results of 10-years studies]. 61
10881659 2000
756
[Clinical features of pulmonary diseases caused by chrysotile asbestos dust]. 61
11280281 2000
757
High-resolution computed tomography in cases with environmental exposure to asbestos in Turkey. 61
10773784 2000
758
Asbestos-Related Pleural Thickening is Independently Associated With Lower Levels of Lung Function and with Shortness of Breath. 61
26368623 2000
759
Occurrence of pulmonary diseases in steel mill workers. 61
10967840 2000
760
[Chrysotile asbestos: biological effects, the work environment highest allowable concentration and neoplasm risk]. 61
11002475 2000
761
The use of a task-based exposure assessment model (T-BEAM) for assessment of metal fume exposures during welding and thermal cutting. 61
10660986 2000
762
[Asbestosis]. 61
10897851 1999
763
Mortality patterns among electrical workers employed in the U.S. construction industry, 1982-1987. 61
10561683 1999
764
[Risk assessment of benign asbestosis (dose-effect relationship, time-effect relationship, co-factors)]. 61
10897848 1999
765
[Social impact of screening and of medical surveillance on people exposed to asbestos]. 61
10897854 1999
766
[Medical impact of screening of broncho-pulmonary cancer in subjects exposed to asbestos]. 61
10897852 1999
767
Assessment of health-related quality of life in patients with interstitial lung disease. 61
10559073 1999
768
[Diagnosis of malignant pleural mesothelioma and asbestosis]. 61
10590773 1999
769
Effect of asbestos-related pleural fibrosis on excursion of the lower chest wall and diaphragm. 61
10556113 1999
770
Recent trends of age-specific pneumoconiosis mortality rates in the United States, 1985-1996: coal workers' pneumoconiosis, asbestosis, and silicosis. 61
10633240 1999
771
[High resolution computerized tomography in the diagnosis of silicosis and mixed dust pneumoconiosis]. 61
10771741 1999
772
[High resolution computerized tomography in the diagnosis of asbestosis]. 61
10771740 1999
773
Asbestosis and small cell lung cancer in a clutch refabricator. 61
10615292 1999
774
k-ras mutation and occupational asbestos exposure in lung adenocarcinoma: asbestos-related cancer without asbestosis. 61
10493509 1999
775
Asbestosis in Malaysia: report on first two cases. 61
11045065 1999
776
Asbestosis. 61
10510023 1999
777
Carboxyterminal propeptide of type I procollagen in ELF: elevation in asbestosis, but not in pleural plaque disease. 61
10543275 1999
778
Cellular and molecular mechanisms of asbestos-induced fibrosis. 61
10395285 1999
779
Fatalities from occupational diseases in Connecticut. 61
10500343 1999
780
p53 protein, EGF receptor, and anti-p53 antibodies in serum from patients with occupationally derived lung cancer. 61
10471051 1999
781
Role of transcription factor NF-kappaB in asbestos-induced TNFalpha response from macrophages. 61
10486238 1999
782
The hazards of chrysotile asbestos: a critical review. 61
10441898 1999
783
Cohort mortality study of women compensated for asbestosis in Italy. 61
10361597 1999
784
Chrysotile-mediated imbalance in the glutathione redox system in the development of pulmonary injury. 61
10378448 1999
785
Occupational cancer in central European countries. 61
10350511 1999
786
A retired shipyard worker with rapidly progressive pulmonary interstitial fibrosis. 61
10090713 1999
787
[Contribution of high-resolution volume computed tomography (HRVCT) for the exploration of diffuse pulmonary infiltrative disorders]. 61
10339762 1999
788
Asbestos exposure, asbestosis, and lung cancer. 61
10027425 1999
789
Asbestosis: a marker for the increased risk of lung cancer among workers exposed to asbestos. 61
10027457 1999
790
Increased serum concentrations of growth factor receptors and Neu in workers previously exposed to asbestos. 61
10448316 1999
791
Incidence of cancer among Finnish patients with asbestos-related pulmonary or pleural fibrosis. 61
10334642 1999
792
[Clinical course of asbestosis under the existing conditions in extraction and processing of serpentine asbestos]. 61
10424073 1999
793
Pulmonary asbestosis associated to pleural non-Hodgkin lymphoma. 61
10228504 1999
794
Lung disease at high altitude. 61
10634992 1999
795
[Asbestosis]. 61
10028547 1999
796
[Nonmalignant asbestos-related diseases]. 61
10028550 1999
797
A historical cohort mortality study of workers exposed to asbestos in a refitting shipyard. 61
10052294 1999
798
Asbestos toxicity: an immunologic perspective. 61
10372416 1999
799
An expert system for the evaluation of historical asbestos exposure as diagnostic criterion in asbestos-related diseases. 61
10028894 1999
800
Compensating the workers: industrial injury and compensation in the British asbestos industry, 1930s-60s. 61
19459260 1999
801
[Asbestos exposure and pleuropulmonary cancer]. 61
10028551 1999
802
[Occupational problems of serpentine asbestos in industry (history and trends)]. 61
10424072 1999
803
[Asbestos exposure and pleuropulmonary cancer]. 61
9923026 1998
804
Asbestos lung burden and asbestosis after occupational and environmental exposure in an asbestos cement manufacturing area: a necropsy study. 61
9924446 1998
805
Expression of cyclooxygenase-2 in human lung carcinoma. 61
9823297 1998
806
Health effects of asbestos exposure in humans: a quantitative assessment. 61
10217936 1998
807
[The mortality due to pulmonary silicosis in the Tuscany region in the last decade demonstrates that the health effects of work exposure to silica are still marked]. 61
10052260 1998
808
Follow-up of asbestosis patients and predictors for radiographic progression. 61
9826079 1998
809
Lung health among boilermakers in Edmonton, Alberta. 61
9750945 1998
810
Re: An early study of pulmonary asbestosis among manufacturing workers: original data and reconstruction of the 1932 cohort. 61
9750949 1998
811
New technologies in diagnosing occupational asbestosis. 61
10376357 1998
812
[Non-malignant asbestos-related diseases]. 61
9805758 1998
813
[Asbestos: current knowledge and perspectives]. 61
9805972 1998
814
Asbestos-related x-ray changes in foundry workers. 61
9651631 1998
815
[Pleural malignant mesothelioma with osseous cartilaginous and rhabdomyogenic differentiation]. 61
9844389 1998
816
[Pneumocystis carinii pneumopathy in rheumatoid polyarthritis treated by methotrexate in a patient with pulmonary asbestosis]. 61
9775079 1998
817
Asbestos-induced lung epithelial permeability: potential role of nonoxidant pathways. 61
9700086 1998
818
Pulmonary function of nonsmoking female asbestos workers without radiographic signs of asbestosis. 61
9709994 1998
819
An overview of the role of mineral solubility in silicosis and asbestosis. 61
9630443 1998
820
Interstitial lung disease more than 40 years after a 5 year occupational exposure to talc. 61
9657588 1998
821
Progression of asbestosis predicts lung cancer. 61
9631787 1998
822
[Rolled atelectasis and asbestosis. Apropos of 26 patients]. 61
9677636 1998
823
Sherlock Holmes, Albrecht Dürer, and Socrates: The International Labour Office radiographic Classification of Pneumoconioses reassessed for asbestosis. 61
9631773 1998
824
Fibroblast mitogens in bronchoalveolar lavage (BAL) fluid from asbestos-exposed subjects with and without clinical evidence of asbestosis: no evidence for the role of PDGF, TNF-alpha, IGF-1, or IL-1 beta. 61
9713348 1998
825
Mechanisms in the pathogenesis of asbestosis and silicosis. 61
9603153 1998
826
Asbestosis, pleural plaques and diffuse pleural thickening: three distinct benign responses to asbestos exposure. 61
9648950 1998
827
Proportionate mortality among union members employed at three Texas refineries. 61
9513640 1998
828
Asbestos in the lungs of persons exposed in the USA. 61
9689804 1998
829
Adenocarcinoma simulating mesothelioma: a clinicopathologic and immunohistochemical study of 29 cases. 61
9845725 1998
830
Radiographic abnormalities among Finnish construction, shipyard and asbestos industry workers. 61
9630058 1998
831
Job-related diseases and occupations within a large workers' compensation data set. 61
9481418 1998
832
Stress associated with asbestosis: the trauma of waiting for death. 61
9589511 1998
833
Participation of iron and nitric oxide in the mutagenicity of asbestos in hgprt-, gpt+ Chinese hamster V79 cells. 61
9515798 1998
834
An updated mortality study of workers at a petroleum refinery in Beaumont, Texas. 61
9408530 1998
835
[Cause-specific mortality of asbestos-cement workers compensated for asbestosis in the city of Bari]. 61
9621499 1998
836
Magnetic resonance imaging of the thorax in the evaluation of asbestosis. 61
9543293 1998
837
Silicosis, mixed dust pneumoconiosis, and lung cancer. 61
9358915 1997
838
Histopathological features of pulmonary asbestosis with particular emphasis on the comparison with those of usual interstitial pneumonia. 61
9540344 1997
839
[Response to Dr. M. Zavalić (Arh Hig Rada Toksikol 1997;48:259-62) letter to the editor on asbestosis]. 61
9721461 1997
840
Professor Matthew Stewart: asbestosis research 1929-1934. 61
9327084 1997
841
Loss of lung function among sheet metal workers: ten-year study. 61
9327069 1997
842
Pulmonary asbestosis: radiologic-pathologic brief report. 61
9409196 1997
843
Neurological signs in relation to cancer in patients with asbestosis. 61
9404323 1997
844
Radiographic asbestosis is not a prerequisite for asbestos-associated lung cancer in Ontario asbestos-cement workers. 61
9258387 1997
845
Asbestos, asbestosis, and lung cancer: observations in Quebec chrysotile workers. 61
9400709 1997
846
Pulmonary involvement in unusual multisystem disorders. 61
9331542 1997
847
Immunohistochemical localization of transforming growth factor beta isoforms in asbestos-related diseases. 61
9400723 1997
848
Exposure-response analysis of risk of respiratory disease associated with occupational exposure to chrysotile asbestos. 61
9423577 1997
849
Asbestos, asbestosis, and cancer: the Helsinki criteria for diagnosis and attribution. 61
9322824 1997
850
Exposure and mineralogical correlates of pulmonary fibrosis in chrysotile asbestos workers. 61
9326158 1997
851
Asbestos causes translocation of p65 protein and increases NF-kappa B DNA binding activity in rat lung epithelial and pleural mesothelial cells. 61
9250152 1997
852
Clinical predictors of mortality from asbestosis in the North American Insulator Cohort, 1981 to 1991. 61
9230732 1997
853
Malignant mesothelioma in south east England: clinicopathological experience of 272 cases. 61
9227715 1997
854
Iron mobilization from crocidolite as enhancer of collagen content in rat lung fibroblasts. 61
9264318 1997
855
Analysis of asbestos bodies in BAL from subjects with particular exposures. 61
9131224 1997
856
Cancer incidence and mortality among Finnish asbestos sprayers and in asbestosis and silicosis patients. 61
9131223 1997
857
[On the letter to the editor published in Arhiv za Higijenu Rada i Toksikologiu 1996; 47:421-423 on occupational asbestosis]. 61
9471971 1997
858
Respiratory impairments due to dust exposure: a comparative study among workers exposed to silica, asbestos, and coalmine dust. 61
9099350 1997
859
Diagnosis of asbestosis. Primum non nocere. 61
9149605 1997
860
Asbestosis and silicosis. 61
9142077 1997
861
[Follow-up of intermittent self-ventilation (ISB). Mortality and causes]. 61
9235478 1997
862
Asbestos, asbestosis, pleural plaques and lung cancer. 61
9167232 1997
863
Relationship between Asbestos Exposures and 8-Hydroxydeoxyguanosine Levels in Leukocytic DNA of Workers at a Chinese Asbestos-material Plant. 61
9891108 1997
864
Occupational Exposures to Asbestos in Brazil. 61
9891113 1997
865
An early study of pulmonary asbestosis among manufacturing workers: original data and reconstruction of the 1932 cohort. 61
9055956 1997
866
The glutathione S-transferase theta and mu deletion polymorphisms in asbestosis. 61
9055949 1997
867
[Further evaluation of occupational activities of recipients of compensation for asbestosis]. 61
9312667 1997
868
Proportionate mortality among unionized construction ironworkers. 61
9028434 1997
869
Hospital records: an underutilized source of information regarding occupational diseases and exposures. 61
8986261 1997
870
Immunohistochemical localization of transforming growth factor-beta and insulin-like growth factor-I in asbestosis in the sheep model. 61
9049666 1997
871
Malignant mesothelioma in women. 61
9575374 1997
872
Distinction between pleural mesothelioma and pulmonary adenocarcinoma using MOC31 in an asbestos sprayer. 61
9091974 1997
873
Asbestosis: clinical spectrum and pathogenic mechanisms. 61
9012357 1997
874
[Biological autoimmune syndrome with antiphospholipid antibodies in occupational asbestosis]. 61
9161568 1997
875
[Lung cancers attributable to asbestos on a pathological basis]. 61
9377742 1997
876
[Asbestos fiber count in extra-pulmonary tissues]. 61
9377743 1997
877
[Characteristics of respiratory and cardiovascular systems of workers with extended length of service at asbestos plants]. 61
9190265 1997
878
Chrysotile asbestos and H2O2 increase permeability of alveolar epithelium. 61
9028796 1997
879
Retention of asbestos fibres in lungs of workers with asbestosis, asbestosis and lung cancer, and mesothelioma in Asbestos township. 61
8994398 1996
880
Glutathione S-transferase and N-acetyltransferase genotypes and asbestos-associated pulmonary disorders. 61
8961976 1996
881
Mortality of Carpenters' Union members employed in the U.S. construction or wood products industries, 1987-1990. 61
8914714 1996
882
Asbestos induction of nuclear transcription factors and interleukin 8 gene regulation. 61
8969274 1996
883
Pleural mesothelioma: an approach to diagnostic problems. 61
9441114 1996
884
Relation of spirometric function to radiographic interstitial fibrosis in two large workforces exposed to asbestos: an evaluation of the ILO profusion score. 61
8994399 1996
885
[Criteria for diagnosis of occupational asbestosis of the pulmonary parenchyma and pleura]. 61
9148697 1996
886
Asbestos induces apoptosis in human alveolar macrophages. 61
8944725 1996
887
Silicosis among foundry workers. Implication for the need to revise the OSHA standard. 61
8890667 1996
888
Lung cancer and asbestos exposure: asbestosis is not necessary. 61
8892544 1996
889
[A mortality study of recipients of compensation for asbestosis in Italy (1980-1990)]. 61
9045026 1996
890
Lung cinescintigraphy in the dynamic assessment of ventilation and mucociliary clearance of asbestos cement workers. 61
8882120 1996
891
Asbestos exposure, asbestosis, and asbestos-attributable lung cancer. 61
8869346 1996
892
Non-ischemic myocardial fibrosis after long-term asbestos exposure. 61
8894733 1996
893
[Peritoneal mesothelioma. Contribution of MRI. Apropos of a case]. 61
8760617 1996
894
Asbestos bodies in sputum of asbestos exposed workers. 61
8956540 1996
895
Malignant epithelial mesothelioma of the peritoneum: observations on a problem case. 61
8837340 1996
896
[On the article by M. Zavalić, A. Bogadi-Sare "Criteria for diagnosis of occupational asbestosis of the pulmonary parenchyma and pleura"]. 61
8967833 1996
897
Pulmonary fibrosis and lung cancer in the United States: analysis of the multiple cause of death mortality data, 1979 through 1991. 61
8638179 1996
898
[Study on correlation between chest X-P course findings and change in antinuclear antibody in asbestos plant employees]. 61
8689500 1996
899
Approaches for assessing the efficacy of occupational health and safety standards. 61
8728138 1996
900
Occupational respiratory diseases in Singapore. 61
8942254 1996
901
Asbestos exposure and asbestosis. 61
8676332 1996
902
The pneumoconioses. 61
9363126 1996
903
The molecular epidemiology of oncoproteins. Serum p53 protein in patients with asbestosis. 61
8598138 1996
904
[A 5-year before-and-after comparison of lung function in asbestos workers]. 61
9208631 1996
905
[Tumor mortality and from other causes in asbestos cement workers at the Casale Montferrato plant]]. 61
8926916 1996
906
Clara cell protein (CC-16) and surfactant-associated protein A (SP-A) in asbestos-exposed workers. 61
8620724 1996
907
TGF-beta 1, but not TGF-beta 2 or TGF-beta 3, is differentially present in epithelial cells of advanced pulmonary fibrosis: an immunohistochemical study. 61
8630262 1996
908
Oxidized BAL fluid proteins in patients with interstitial lung diseases. 61
8777969 1996
909
Unrecognized asbestos-induced disease. 61
8821361 1996
910
Malignant peritoneal mesothelioma following asbestos exposure. 61
9216805 1996
911
Iron-induced carcinogenesis: the role of redox regulation. 61
8904296 1996
912
[Diagnosis of occupational asbestosis]. 61
10596176 1996
913
[Asbestosis and primary Gougerot-Sjögren syndrome]. 61
8959137 1996
914
Elevated interleukin-8 in the alveolitis of individuals with asbestos exposure. 61
8720280 1996
915
[Exposure to asbestos and levels of selected tumor biomarkers]. 61
8657007 1996
916
Differentiation of the ILO boundary chest roentgenograph (0/1 to 1/0) in asbestosis by high-resolution computed tomography scan, alveolitis, and respiratory impairment. 61
8871331 1996
917
Comparative analysis of p16/CDKN2, p53 and ras gene alterations in human non-small cell lung cancers, with and without associated pulmonary asbestosis. 61
21544334 1996
918
Serum oncoproteins in asbestosis patients. 61
7497643 1995
919
[Liability in occupational asbestosis and its harmful sequelae]. 61
8670016 1995
920
Asbestos exposure and asbestosis: clarifying terminology and avoiding confusion. 61
8786585 1995
921
[Criteria for diagnosis of occupational asbestosis of the pulmonary parenchyma and pleura]. 61
8670014 1995
922
[Standardization of diagnostic criteria for occupational asbestosis of the lungs and lung parenchyma]. 61
8670015 1995
923
Differences in occupational mortality from pleural cancer, peritoneal cancer, and asbestosis. 61
8535500 1995
924
Carcinosarcoma of lung associated with asbestosis. 61
8575744 1995
925
[Computed tomography of pneumoconiosis]. 61
8528949 1995
926
Emphysema in silica- and asbestos-exposed workers seeking compensation. A CT scan study. 61
7656611 1995
927
Asbestos-induced visceral pleural fibrosis reduces pulmonary compliance. 61
7485190 1995
928
Patterns of inflammation, cell proliferation, and related gene expression in lung after inhalation of chrysotile asbestos. 61
7677184 1995
929
Occupational respiratory cancer and exposure to asbestos: a case-control study in a cohort of workers in the electricity and gas industry. 61
7485188 1995
930
CT findings in pulmonary asbestosis. 61
7618590 1995
931
Airways obstruction from asbestos exposure and asbestosis revisited. 61
7781376 1995
932
Value of adenosine deaminase in the diagnosis of tuberculous pleural effusions in young patients in a region of high prevalence of tuberculosis. 61
7638798 1995
933
Do radiographic criteria for emphysema predict physiologic impairment? 61
7750310 1995
934
Tumour necrosis factor-alpha (TNF-alpha) in patients who have asbestosis and develop cancer. 61
7795753 1995
935
Consequences of long-lasting asbestos-exposure: peripheral blood parameters in shipyard workers with and without asbestosis. 61
7580111 1995
936
[The importance of thoracic radiology for public health since 1896]. 61
7610249 1995
937
[Quantitative computed tomography of the lung in the early diagnosis of asbestosis: initial results in asbestos-exposed navy personnel]. 61
7749083 1995
938
The pneumoconioses. 61
15786596 1995
939
[Asbestos: past, present and future]. 61
7892557 1995
940
[Fatal pleural mesothelioma diseases caused by familial household contacts with asbestos fiber dust]. 61
7724503 1995
941
Benign manifestations of asbestosis. 61
7861786 1995
942
CT for asbestosis: value and limitations. 61
7998571 1995
943
[The incidence of airway obstruction in asbestosis]. 61
7892153 1995
944
Pneumoconiosis and associated medical conditions. 61
7900728 1995
945
CT quantification of interstitial fibrosis in patients with asbestosis: a comparison of two methods. 61
7998570 1995
946
Changing approaches to assessment of environmental inhalation risk: a case study. 61
7898410 1995
947
Asbestos inhalation, not asbestosis, causes lung cancer. 61
7892836 1994
948
Does asbestos or asbestosis cause carcinoma of the lung? 61
7892835 1994
949
The detection of increased amounts of the extracellular domain of the epidermal growth factor receptor in serum during carcinogenesis in asbestosis patients. 61
7884573 1994
950
Asbestos-related disease associated with exposure to asbestiform tremolite. 61
7892832 1994
951
A protective role for T lymphocytes in asbestos-induced pulmonary inflammation and collagen deposition. 61
7946383 1994
952
Airways obstruction from asbestos exposure. Effects of asbestosis and smoking. 61
7924474 1994
953
[A case of asbestosis with long survival by artificial ventilation]. 61
7844904 1994
954
Usefulness of the Nd:YAG laser in parenchyma-sparing resection of pulmonary nodular lesions. 61
7839468 1994
955
An autopsy case of malignant mesothelioma associated with asbestosis. 61
7834080 1994
956
Correspondence Re: P.T. Cagle, R. Wessels, and S.D. Greenberg. Concurrent mesothelioma and adenocarcinoma of the lung in a patient with asbestosis. Mod Pathol 6:438, 1993. 61
7838847 1994
957
Inherited glutathione-S-transferase deficiency is a risk factor for pulmonary asbestosis. 61
8000297 1994
958
Specificity of high-resolution CT findings in pulmonary asbestosis: do patients scanned for other indications have similar findings? 61
8079842 1994
959
Environmental airborne tremolite asbestos pollution and pleural plaques in Afghanistan. 61
8082397 1994
960
Fiber burden and patterns of asbestos-related disease in workers with heavy mixed amosite and chrysotile exposure. 61
8087335 1994
961
High-resolution CT of the lung in asbestos-exposed subjects. Comparison of low-dose and high-dose HRCT. 61
8086257 1994
962
Distribution of transforming growth factor-beta 1, fibronectin, and smooth muscle actin in asbestos-induced pulmonary fibrosis in rats. 61
8027525 1994
963
Macrophage-associated responses to chrysotile. 61
7978983 1994
964
[Asbestos-related lesions detected by high-resolution CT scanning in asymptomatic workers. Specificity, relation to the duration of exposure and cigarette smoking]. 61
7955966 1994
965
Biological indicators of chrysotile exposure. 61
7978972 1994
966
Symptoms and pulmonary functions as measures of morbidity. 61
7978980 1994
967
Other diseases in animals. 61
7978981 1994
968
The human evidence: parenchymal and pleural changes. 61
7978979 1994
969
Biological effects: asbestos-cement manufacturing. 61
7978975 1994
970
Dose-responsive increases in pulmonary fibrosis after inhalation of asbestos. 61
8025751 1994
971
Asbestos content of bronchoalveolar lavage fluid. A comparison of light and scanning electron microscopic analysis. 61
8042413 1994
972
Examination of lungs for asbestosis and asbestos bodies. 61
7991297 1994
973
Pneumoconioses in Bulgaria--prevalence, development, prognosis and prevention. 61
7812246 1994
974
Serum levels of growth-factor receptors, egfr and Neu in asbestosis patients - a follow-up-study. 61
21567014 1994
975
Environmental asbestosis complicated by lung cancer. 61
8181367 1994
976
Institutional and patient criteria for heart-lung transplantation. 61
7712318 1994
977
Asbestos-induced pleural fibrosis and impaired exercise physiology. 61
8181322 1994
978
Conventional and high-resolution CT in asymptomatic asbestos-exposed workers. 61
8192957 1994
979
Third wave of asbestos-related disease from secondary use of asbestos. A case report from industry. 61
7740353 1994
980
Four cases of mesothelioma among Finnish anthophyllite miners. 61
8130852 1994
981
[Lung and heart-lung transplantation: indications, complications and prognosis]. 61
8183861 1994
982
Is there an association between pleural plaques and lung cancer without asbestosis? 61
8016601 1994
983
[Contribution and role of polymorphonuclear leucocytes in inflammatory reactions of asbestosis]. 61
7854113 1994
984
[Asbestosis and the other silicate pneumoconiosis]. 61
8152039 1994
985
[Computed tomography of pneumoconioses]. 61
8092754 1994
986
High-resolution CT-derived measures of lung density are valid indexes of interstitial lung disease. 61
8175517 1994
987
High-resolution computed tomography in the early detection of asbestosis. 61
8175184 1994
988
Letter from Dust Diseases Board of New South Wales. Examination of lungs for asbestosis and asbestosis bodies. 61
8165035 1994
989
Asbestos fiber analysis in seven asbestosis cases. 61
8117151 1994
990
[Asbestosis]. 61
8152042 1994
991
[The role of pulmonary macrophages in the development of pulmonary fibrosis caused by asbestos]. 61
7968504 1994
992
[The role of pulmonary epithelial cells in lung cellular reaction to asbestos exposure]. 61
7997153 1994
993
Pleural plaques and risk for bronchial carcinoma and mesothelioma. A prospective study. 61
8275722 1994
994
Correspondence re: Philip T. Cagle, Robert Wessels, and S. Donald Greenberg. Concurrent mesothelioma and adenocarcinoma of the lung in a patient with asbestosis. Mod Pathol 6:438, 1993. 61
8159646 1994
995
Lung crackle characteristics in patients with asbestosis, asbestos-related pleural disease and left ventricular failure using a time-expanded waveform analysis--a comparative study. 61
8029512 1994
996
[Criteria for recognizing asbestosis as an occupational disease]. 61
8192609 1993
997
Malignant mesothelioma induced in baboons by inhalation of amosite asbestos. 61
8311096 1993
998
Pulmonary complications of asbestos exposure. 61
8249778 1993
999
End-stage lung disease: CT findings in 61 patients. 61
8234691 1993
1000
Humoral immunological profile of workers exposed to asbestos in asbestos mines. 61
8132229 1993
1001
[The content of asbestos bodies in the bronchoalveolar fluid as a parameter of an increased pulmonary asbestos load]. 61
8253027 1993
1002
Study of occupational lung cancer in asbestos factories in China. 61
8280629 1993
1003
[Ecogenetic aspects of the study of phenotypes and levels of beta-aminoisobutyric acid excretion]. 61
8307374 1993
1004
[Genetic polymorphism of haptoglobin and quantitative changes in its levels during exposure to asbestos]. 61
8307377 1993
1005
Hyaline splenic and hepatic plaques. Correlation with cirrhosis, pulmonary tuberculosis, and asbestos exposure. 61
8215823 1993
1006
Radiographic abnormalities and mortality in subjects with exposure to crocidolite. 61
8217849 1993
1007
[The association of genetic and functional variability of alpha 1-antitrypsin in asbestosis]. 61
8307361 1993
1008
High-resolution CT of the lungs. 61
8362698 1993
1009
Asbestos, asbestosis, and lung cancer. 61
8248104 1993
1010
Gamma/delta T-lymphocytes in advanced pulmonary asbestosis. 61
8140322 1993
1011
The importance of lung function, non-malignant diseases associated with asbestos, and symptoms as predictors of ischaemic heart disease in shipyard workers exposed to asbestos. 61
8398871 1993
1012
Problems in assessing the relative predictive value of internal markers versus external exposure in chronic disease epidemiology. 61
8220095 1993
1013
Asbestos directly increases lung epithelial permeability. 61
7692746 1993
1014
Computed tomography in the early detection of asbestosis. 61
8398855 1993
1015
Asbestosis mortality in Italy. 61
8255259 1993
1016
Relative release of interleukin-1 beta and interleukin-1 receptor antagonist by alveolar macrophages. A study in asbestos-induced lung disease, sarcoidosis, and idiopathic pulmonary fibrosis. 61
8325116 1993
1017
Concurrent mesothelioma and adenocarcinoma of the lung in a patient with asbestosis. 61
8415588 1993
1018
Fiber burden and patterns of asbestos-related disease in chrysotile miners and millers. 61
8391235 1993
1019
The relationship between HLA-A, B, DQ, and DR antigens and asbestos-induced lung disease. 61
8325081 1993
1020
Bronchoalveolar lavage and 99mTc-DTPA clearance as prognostic factors in asbestos workers with and without asbestosis. 61
8209056 1993
1021
High resolution pulmonary computed tomography scans quantified by analysis of density distribution: application to asbestosis. 61
8329317 1993
1022
[Detection of asbestos in thoracic lymph nodes in patients with asbestosis]. 61
8337227 1993
1023
Asbestos-related pleural plaques and lung cancer. 61
8404113 1993
1024
Characterization of asbestos fibers in lungs and mesotheliomatous tissues of baboons following long-term inhalation. 61
8328475 1993
1025
Asbestos-related radiographic abnormalities in elevator construction workers. 61
8503542 1993
1026
Asbestos and lung cancer in Glasgow and the west of Scotland. 61
8518676 1993
1027
Enhanced IL-1 beta and tumor necrosis factor-alpha release and messenger RNA expression in macrophages from idiopathic pulmonary fibrosis or after asbestos exposure. 61
8473757 1993
1028
A diagnostic approach to asbestosis, utilizing clinical criteria, high resolution computed tomography, and gallium scanning. 61
8338599 1993
1029
Asbestos-related pericardial thickening detected by magnetic resonance imaging. 61
9728233 1993
1030
Prevalence of small opacities in chest radiographs of nickel sinter plant workers. 61
8507595 1993
1031
Distribution of asbestos bodies in the human lung as determined by bronchoalveolar lavage. 61
8484633 1993
1032
AIDS and malignant mesothelioma--is there a connection? 61
8131480 1993
1033
Pulmonary function in asbestosis and asbestos-related pleural disease. 61
8472663 1993
1034
Radiological case of the month. Asbestosis-related round atelectasis. 61
8486591 1993
1035
Absence of amosite asbestos in airway mucosa of non-smoking long term workers with occupational exposure to asbestos. 61
8388242 1993
1036
Asbestos-induced lung disease. 61
8354168 1993
1037
Lobe of origin of lung cancer among asbestos-exposed patients with or without diffuse interstitial fibrosis. 61
8391162 1993
1038
Diagnosis of asbestosis by a time expanded wave form analysis, auscultation and high resolution computed tomography: a comparative study. 61
8511731 1993
1039
Liposarcomatous differentiation in diffuse pleural mesothelioma. 61
8511746 1993
1040
Malignant mesothelioma in women. 61
8497827 1993
1041
Bronchoalveolar lavage fluid proteins in human lung disease: analysis by two-dimensional electrophoresis. 61
8486137 1993
1042
[CT findings of diffuse pleural disease--alteration of pleura and extrapleural fat]. 61
8474862 1993
1043
Systemic lupus erythematosus. 61
8519077 1993
1044
[A case of pulmonary asbestosis with slightly increased serum IgE concentration and histopathological changes resembling DIP]. 61
8515602 1993
1045
Total lung capacity in asbestosis: a comparison of radiographic and body plethysmographic methods. 61
8427297 1993
1046
Lymphocyte B and T cell subsets in peripheral blood from patients with asbestosis. 61
8382078 1993
1047
Measuring lung volumes in advanced asbestosis: comparability of plethysmographic and radiographic versus helium rebreathing and single breath methods. 61
8497680 1993
1048
Secreted extracellular domains of macrophage scavenger receptors form elongated trimers which specifically bind crocidolite asbestos. 61
8381434 1993
1049
[Interleukin-1 beta production by alveolar macrophages in cases of asbestos exposure]. 61
8515598 1993
1050
Quantitative analysis of 8-hydroxyguanine in peripheral blood cells: an application for asbestosis patients. 61
8406929 1993
1051
Diffuse interstitial lung disease--evaluation with high-resolution computed tomography. 61
7976669 1993
1052
Exporting asbestos: disease and policy in the developing world. 61
8486752 1993
1053
Human alveolar macrophage cytokine release in response to in vitro and in vivo asbestos exposure. 61
8440202 1993
1054
Asbestos disease risk communication conducted by the New Jersey Department of Health. 61
8422066 1993
1055
Pleural thickening: a comparison of oblique chest radiographs and high-resolution computed tomography in subjects exposed to low levels of asbestos pollution. 61
8314611 1993
1056
Asbestos-related disease in the workplace and the environment: controversial issues. 61
8107699 1993
1057
[Evolution of radiologic changes in lungs of workers occupationally exposed to asbestos dust]. 61
8231794 1993
1058
Distant health effects of using asbestos in shipyards and in co-operating plants. 61
7580350 1993
1059
[Epidemiology of chronic, precancerous and oncologic diseases in workers of asbestos and cement industry]. 61
8069507 1993
1060
Role of lipid peroxidation and antioxidants in aging process and thalassemia. 61
1344011 1992
1061
[Factors which may mask a possible safe threshold for asbestos fibre]. 61
1465694 1992
1062
Occupational exposure and respiratory morbidity among asbestos workers in Taiwan. 61
1363633 1992
1063
The histocompatibility antigen in asbestos related disease. 61
1472439 1992
1064
Do silica and asbestosis cause lung cancer? 61
1332640 1992
1065
Computed tomography in the evaluation of benign asbestos-related disorders. 61
1410308 1992
1066
[Quantitative analysis of pneumoconiosis in standard chest radiographs]. 61
1448333 1992
1067
Pulmonary effects of exposure to fine fibreglass: irregular opacities and small airways obstruction. 61
1419860 1992
1068
[Legal cases on the correlation between exposure to asbestos fiber dust and laryngeal cancer]. 61
1418224 1992
1069
[Study on the incidence of coal mine pneumoconiosis and lung cancer in Beijing coal mining district]. 61
1298608 1992
1070
Screening and pathological diagnosis of asbestosis and mesothelioma: a review. 61
1464814 1992
1071
[Silicosis and asbestosis. Epidemiology, screening, prevention]. 61
1455141 1992
1072
Occupational exposure to asbestos and urinary bladder cancer. 61
1324833 1992
1073
Primary prevention of occupational lung disease: a view from the United States. 61
1428804 1992
1074
The Small Area Health Statistics Unit: a national facility for investigating health around point sources of environmental pollution in the United Kingdom. 61
1431704 1992
1075
High resolution computed tomographic assessment of asbestosis and cryptogenic fibrosing alveolitis: a comparative study. 61
1412123 1992
1076
[Three cases of lower respiratory tract infection worsened after rhinovirus infection]. 61
1331264 1992
1077
Prediction of mesothelioma, lung cancer, and asbestosis in former Wittenoom asbestos workers. 61
1606035 1992
1078
Asbestos-related lung disease. 61
1604390 1992
1079
Deposition, clearance, and translocation of chrysotile asbestos from peripheral and central regions of the rat lung. 61
1317793 1992
1080
Chronological assessment of asbestos exposure on cell composition in murine lung. 61
1605166 1992
1081
Ferruginous body counts in sputum as an index of past exposure to mineral fibres. 61
1519873 1992
1082
Asbestos exposure in buildings. 61
1511551 1992
1083
Pseudomesotheliomatous adenocarcinoma: a reappraisal. 61